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ABSTRACT
Joseph Rigdon: Causal Inference for Binary Data with Interference
(Under the direction of Michael Hudgens)
Developing methods to quantify the effects of interventions to prevent infectious diseases
in the presence of interference is the overall objective of this research. Interference is present
when an individual’s outcome is affected by the treatment of any other individuals under
study.
First, two methods are developed for constructing randomization based confidence in-
tervals for the average effect of a treatment on a binary outcome without interference. The
methods are nonparametric and require no assumptions about random sampling from a larger
population. Both of the resulting 1−α confidence intervals are exact and guaranteed to have
width no greater than one. In contrast, previously proposed asymptotic confidence intervals
are not exact and may have width greater than one. The first approach combines Bonferroni
adjusted prediction intervals for the attributable effects in the treated and untreated. The
second method entails inverting a permutation test. While simulations show that the permu-
tation based confidence intervals have smaller average width, the attributable effects based
confidence intervals are more computationally feasible as sample size increases. Extensions
that allow for stratifying on categorical baseline covariates are also discussed.
Secondly, for a two-stage randomized experiment assuming stratified interference, meth-
ods are developed for constructing exact confidence intervals for the direct, indirect, total,
and overall effect of a treatment on a binary outcome. The methods are nonparametric and
require no assumptions about random sampling from a larger population. The new exact con-
fidence intervals are compared via simulation with previously proposed exact and asymptotic
confidence intervals. While the asymptotic intervals do not maintain nominal coverage for
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certain simulation setups, the new exact confidence intervals maintain nominal coverage for
all setups and have narrower width than the previously proposed exact confidence interval.
Thirdly, we consider a Bayesian approach to causal inference with interference in an obser-
vational study under the assumption that the treatment assignment mechanism is ignorable.
We compare the methods via a simulation study to previously proposed IPW estimators. The
methods are applied to data from the 2007 Demographic and Health Survey in the Demo-
cratic Republic of the Congo, examining the impact of individual and community bed net use
on malaria.
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW
1.1 Introduction
Developing methods to quantify the effects of interventions to prevent infectious diseases
in the presence of interference is the overall objective of this research. In a randomized exper-
iment or observational study, interference is present when an individual’s outcome is affected
by the exposure(s) of any other individual(s) under study. Interference is a phenomenon that
appears in many fields of study, e.g., infectious diseases, education, sociology, and various
other settings in which individuals communicate or compete. A canonical example of inter-
ference occurs when vaccinated individuals can protect unvaccinated individuals from disease
when all individuals are in close contact with one another. Standard statistical methods
may indicate that the vaccinated individuals in such a situation are minimally less likely to
develop disease than the unvaccinated, thus leading an investigator to believe that vaccine
is ineffective. This is a possibly erroneous conclusion, as it is plausible that the vaccinated
individuals are protecting the group at large from disease, i.e., herd immunity. If interference
is not accounted for in such a situation, a potentially useful vaccine could be deemed ineffec-
tive. Therefore, it is of great public health importance to properly evaluate vaccines in the
presence of interference.
Building upon ideas in Halloran et al. (1991), Hudgens and Halloran (2008) defined four
treatment effects of interest in the presence of interference for a finite population using the
potential outcomes framework. The direct effect of treatment is the difference in outcomes
when vaccinated versus not at a fixed level of group treatment coverage. The indirect effect
of treatment is the difference in outcomes when unvaccinated in a low treatment coverage
group versus unvaccinated in a high treatment coverage group. The indirect effect measures
the “spillover” effects of vaccine. The total causal effect is the difference in outcomes when
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unvaccinated in a low treatment coverage group versus vaccinated in a high treatment coverage
group. The overall effect of treatment is the difference in outcomes in a low treatment coverage
group versus a high treatment coverage group. The focus of this research is to develop novel
statistical methods to draw inference about the direct, indirect, total and overall effect of a
treatment in the presence of interference.
To accomplish these goals, we 1) develop exact confidence intervals for the direct effect of
treatment on a binary outcome when interference is not present in a randomized trial with
one or more groups, then 2) develop exact confidence intervals for the four treatment effects
on a binary outcome in a randomized trial when interference is present, and conclude with 3)
building methods for inference on the four effects in a non-randomized real setting in which
interference may be present.
1.2 Motivating Examples
Oral cholera vaccines were administered to residential areas, called baris, in Bangladesh in
an individually randomized placebo-controlled trial (Ali et al., 2005). The baris had varying
levels of proportion of residents who received vaccine, or vaccine coverage, due to differing
levels of participation in the trial. Summary measures of the incidence of cholera during the
first year of follow-up of the trial are displayed in Table 1.1.
Table 1.1: Risk of cholera in recipients of killed oral cholera vaccines of placebo, by level of
coverage of the bari during one year of follow-up
Vaccine recipients Placebo recipients
Coverage Population Total Cases Risk per 1,000 Total Cases Risk per 1,000
>50% 22,394 12,541 16 1.27 6,082 9 1.47
41-50% 24,159 11,513 26 2.26 5,801 27 4.65
36-40% 24,583 10,772 17 1.58 5,503 26 4.72
28-35% 25,059 8,883 22 2.48 4,429 26 5.87
<28% 24,954 5,627 15 2.66 2,852 20 7.01
In Table 1.1, placebo and vaccine recipients in the >50% coverage group had nearly the
same risk of cholera, yet placebo recipients in the <28% coverage group werre nearly three
2
times as likely to experience cholera as vaccine recipients. When more individuals in a group
were vaccinated, the outcome of a single individual, regardless of vaccine status, is more likely
to be no cholera. Thus, interference may be present, as an individual’s cholera outcome is
affected by the vaccine status of other members of the group.
In addition to cholera, malaria is another infectious disease setting where interference is
found. Treated and untreated bed nets are a frequently used intervention to protect individ-
uals in at-risk areas from mosquitos infected with malaria. Empirical evidence indicates that
as the bed net coverage level goes up in a group of individuals, malaria incidence tends to
go down (Hii et al., 2001; Hawley et al., 2003; Messina et al., 2011). In the Wosera area of
Papua New Guinea, Hii et al. (2001) found that untreated bed nets have a substantial impact
on malaria prevalence in high coverage areas that is greater than can be accounted for by
personal protection. In the Nyanza Province in western Kenya, Hawley et al. (2003) found
a similar strong community effect of treated bed nets, hypothesizing that these effects were
due to reduced longevity of mosquito populations forced to expend extra energy in search of
human blood. Using data collected in the 2007 Demographic and Health Survey (DHS) in
the Democratic Republic of the Congo (DRC), Messina et al. (2011) modeled malaria status
as a function of group and individual covariates in a multilevel logistic regression. Individual
bed net usage was significant when entered alone in the model, but was no longer significant
when group level bed net coverage was included in the model, suggesting that herd immunity
may be occurring within communities. In the final section of this dissertation, we develop
methods for inference on the four effects of interest in a re-analysis of the 2007 DHS data.
1.3 Causal Inference
The fundamental goal of many public health studies is draw inferences on the cause of a
health-related outcome. As Gelman (2011) states, there are two broad classes of inferential
questions to consider in a causal analysis. First, there are forward inferential questions that
follow individuals with a treatment or exposure and monitor outcomes. Does a novel treat-
ment lead to longer survival time? If I study more, will I score higher on the test? Second,
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there are reverse inferential questions that start with an outcome in mind and try to identify
its cause. Why did a certain group of students perform best on the SAT? Why did the bas-
ketball team win the title? This dissertation will be concerned with questions belonging to
the first broad category.
Randomized experiments are the ideal means through which investigators can answer
forward inferential questions about causality. The act of randomizing treatments leads to
unbiased estimators of treatment effects and facilitates the use of simple and conventional
statistical methods. Going beyond conventional methods, the paradigm of potential outcomes
offers intuitive and transparent statements about causality in a randomized experiment (Little
and Rubin, 2000). Extending the ideas of Neyman (1923), Rubin (1974) developed a formal
framework defining causal effects as comparisons of potential outcomes that would have been
observed under different exposures to treatments. In this view, each individual’s potential
outcome on control serves as his or her own control. Conceptual clarity is provided as the
effects of causes, which can be precisely defined using potential outcomes, rather than the
causes of effects are examined (Holland, 1986). As only one outcome is observed per unit, sta-
tistical methods are necessary to make statements about the unobserved potential outcomes
for each unit and thus the causal effects. Greenland (2000) outlined the benefits of such an
approach, also called the “counterfactual” approach. In addition to conceptual clarity, this
approach allows for extensions to more complex settings than randomized experiments such
as observational studies or settings with interference. We will make use of this paradigm to
accomplish all three objectives stated in the introduction.
Consider a study with i = 1, ..., k groups of size ni such that there are n =
∑k
i=1 ni
total individuals in the study. For individual j in group i, let Yij represent the observed
outcome and Zij represent the observed treatment or exposure. Depending on the context of
the investigation, Yij may be binary, ordinal, or continuous. Let Zij be dichotomous where
Zij = 0 indicates no treatment and Zij = 1 indicates treatment.
In the potential outcomes paradigm, Yij is one of many potential outcomes in the set
{yij(z) : z ∈ Z} that could have been revealed by the random variable Zij . Thus, Yij is
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also a random variable. The set {yij(z) : z ∈ Z} could contain a unique potential outcome
for each of the 2n assignments of treatment or no treatment for the n individuals in the
study, but typically the number of potential outcomes per individual are limited by assump-
tions about interference and study design. Additionally, the potential outcome yij(z) could
be viewed as fixed or random depending on the type of inference being used. From the fi-
nite population perspective, yij(z) is fixed and inferential targets are functions of the fixed
potential outcome structure, e.g., the sample average causal effect in group i without interfer-
ence n−1
∑ni
j=1{yij(0)− yij(1)}. From the superpopulation perspective, yij(z) is considered a
random variable and inferential targets are functions of its distribution, e.g., the population
average causal effect in group i without interference E[yi(0)−yi(1)]. In this section, the finite
population perspective is adopted, but in later sections, the superpopulation perspective will
be employed.
In the simplest case with no interference, {yij(z) : z ∈ Z} contains yij(0), the potential
outcome on control, and yij(1), the potential outcome on treatment. In this case, a natural
causal estimand is the direct effect of vaccine, yij(0)−yij(1). Supposing the potential outcomes
were binary, if the direct effect in individual j were 1, it could be concluded that vaccine
prevents disease; however, both potential outcomes are never observed together and therein
lies the necessity for statistical methods.
As Rubin (2005) notes, causal inference is impossible without assumptions and it is the
scientific quality of those assumptions, not their existence, that is critical. A standard as-
sumption in the potential outcomes framework is the stable unit treatment value assumption
(SUTVA) (Rubin, 1980) that assumes 1) there are not multiple forms of treatment and 2)
there is no interference between units (Cox, 1958). In this dissertation, we consider problems
where assumption 2) is violated, i.e., the set {yij(z) : z ∈ Z} contains elements beyond yij(0)
and yij(1).
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1.4 Randomization Based Inference
Any randomized experiment will only reveal one potential outcome for each individual,
necessitating statistical methods to draw inferences about the unobserved potential outcomes.
Randomization based inference can be employed to make inferences about unobserved quan-
tities. Dating back to Fisher (1935), this mode of inference uses the randomization process in
the experimental design to induce the distribution of a test statistic under a null hypothesis.
As no distributional assumptions are needed for the data generating process, no likelihood
function is formed. No assumptions are needed about sampling from a superpopulation as the
target of inference is the study population itself. A classic example of randomization based
inference is Fisher’s Exact Test for binary exposure and outcome data. The distribution of
any cell in the 2 × 2 table formed by the observed data is known be hypergeometric under
the sharp null hypothesis that yj(0) = yj(1) for individuals j = 1, ..., n.
Rubin (1974) delineated two formal benefits of randomization in an experiment in which n
of 2n subjects are randomized to treatment with no interference. First, the observed difference
in the mean of the outcomes of the n subjects who receive control minus the mean of the
outcomes of the n subjects who receive treatment is an unbiased estimator of the average
causal effect
∑2n
j=1{yj(0) − yj(1)} (Neyman, 1923). Second, precise probabilistic statements
can be made indicating how likely the observed difference in treatment group means is under
a “sharp” null hypothesis. Hypotheses tested must be “sharp” in the sense that they specify
all possible potential outcomes. The validity of a hypothesis is tested by re-running the
experiment, i.e., by re-randomizing individuals to treatment or control. A test statistic is
computed under each re-randomization including the observed randomization. If the observed
data test statistic is extreme relative to the test statistics generated by the re-randomizations
under the null hypothesis, then there is evidence that the hypothesis is false.
Stewart (2002) likens randomization based inference to the movie Groundhog Day, in
which Bill Murray’s character re-lives the same day over and over again. The act of re-living
the same day can be thought of as a re-randomization of treatments. Eventually, after enough
iterations of this process, he is able to infer the true structure of his environment and live the
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perfect day. In the vaccine trial setting, this would be analogous to revealing all potential
outcomes and assigning the most beneficial treatment to each individual. The analogy can be
taken a step further in that any inferences that Bill Murray’s character makes in Groundhog
Day only apply to his environment, and that any inferences made in the vaccine trial only
apply to the individuals in the study.
To illustrate these points, consider the following example. Two of four participants are
to be randomized to vaccine. The outcome of interest is the number of visits to the doctor
in the year after vaccine is administered. Assuming no interference is present, each of the
j = 1, ..., 4 individuals has two potential outcomes: yj(0), the number of visits on control, and
yj(1), the number of visits on vaccine. Let τj = yj(0) − yj(1) be the causal effect of vaccine
for individual j. Table 1.2 displays all potential outcomes, half of which can be revealed by
investigation, such that the true average causal effect is τ = (1/4)
∑4
j=1 τj = 4.
Table 1.2: Vaccine trial example with number of visits to doctor in the following year as
outcome
Individual y(0) y(1) τj
1 7 4 3
2 10 5 5
3 5 1 4
4 4 0 4
Let Zj = 1 if randomized to vaccine and 0 if placebo. Let the estimator be τˆ =
(1/2)
∑4
j=1(1 − Zj)yj(0) − (1/2)
∑4
j=1 Zjyj(1). There are
(
4
2
)
equals 6 ways of randomiz-
ing two of four individuals to vaccine, each occurring with equal probability 1/6. The 6
possibilities of the vector of treatments Z with corresponding estimated average causal effect
τˆ are 1100 and 0, 1010 and 4.5, 1001 and 5.5, 0110 and 2.5, 0101 and 3.5, and 0011 and 8.
The estimator τˆ is unbiased as E[τˆ ] = (1/6)(0 + 4.5 + 5.5 + 2.5 + 3.5 + 8) = 4.
To illustrate the second point made by Rubin (1974) about the randomization-based
p-value, let the observed data be Z = 0101 and τˆ = 3.5. As the randomization process
only reveals one potential outcome for each individual, y1(1), y2(0), y3(1), and y4(0) remain
unknown. Under the sharp null hypothesis H0 : τj = τ
0
j for each j, the blanks can be filled
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in. If the missing outcome for individual j is yj(0), it is known under the null as yj(1) + τ
0
j ,
and if the missing outcome is yj(1), it is known under the null as yj(0)− τ0j . For illustration,
consider Fisher’s sharp null that τj = 0 for all j. Under this null, the 6 possibilities of the
vector Z with corresponding estimated average causal effect τˆ are 1100 and -3.5, 1010 and -3.5,
1001 and 1.5, 0110 and 1.5, 0101 and 3.5 (the observed data), and 0011 and 3.5. A measure
of extremeness of the observed τˆ is the proportion of re-randomized τˆ values are farther in
absolute distance from the hypothesized center of the distribution, or the permutation test
p-value p = (1/6)
∑6
c=1 1{|τˆ c − 0| ≥ |τˆ − 0|}, where τˆ c denotes the value of τˆ under re-
randomization c = 1, ..., 6. If p is large, then the observed τˆ is close to the center of the
distribution of τˆ under the null, lending support to the null being true. If p is small, then the
observed τˆ is far from the center of the distribution of τˆ under the null, lending support to
the null being false. In this example, p = 4/6 lends support to the null being true.
1.5 Incorporating Covariate Information
Although the estimator τˆ is unbiased, it can be highly variable. For the data in Table 1.2,
the estimator τˆ can take on a value as large as 8 even though the true τ is equal to 4 in.
Matching units that would respond similarly to vaccine can lower the variance of τ (Rubin,
1974). To illustrate this point, again consider the data in Table 1.2. Individuals 1 and 2 have
similar outcomes on vaccine and placebo and are “matched” in some sense, as are individuals
3 and 4. If randomization is limited so that one individual gets vaccine among 1 and 2 and
only one individual gets vaccine among 3 and 4, the 4 possible values of Z and τˆ are 1010
and 4.5, 1001 and 5.5, 0110 and 2.5, and 0101 and 3.5. The variance of τˆ has been lowered
from 7.4 to 1.7, while τˆ remains unbiased.
This process of matching is straightforward in the physical sciences, where for example
it is easy to apply treatment 1 and treatment 2 to two blocks of wood cut from the same
tree. Matching can become tricky when dealing with humans and social science phenomena.
When many categorical and continuous covariates are collected as in most public health
studies, alternatives to matching include covariance adjustment, propensity score matching,
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and inverse probability weighting.
1.5.1 Covariance Adjustment
Rosenbaum (2002a) maps out a strategy for covariance adjustment based on important
covariates for a continuous outcome. Let y(0) be the vector of potential outcomes on control,
y(1) on treatment, Z the vector of treatment assignments such that m of n receive vaccine, δ
the vector of causal effects such that τ = 1′δ/n, and Y = Z ′y(1) + (1−Z)′y(0), the vector of
observed outcomes. Rosenbaum (2002a) assumes additivity in the sense that only hypotheses
of the form H0 : δ = τ0 are considered, where τ0 is a scalar constant. Let q be the vector
of ranks of y(0) = Y + Zτ0 under the null. Then, the plausibility of H0 can be tested by
comparing the Wilcoxon rank-sum statistic, q′Z, to its distribution under the null, a sum of
m numbers randomly selected from {1, ..., n}, a unimodal distribution with mean m(n+1)/2.
The p-value is the proportion of these sums that are more extreme than the observed q′Z,
i.e., that they are farther in way from m(n + 1)/2 in absolute distance. A 1 − α confidence
interval for τ assuming additivity includes all τ0 such that this p-value is greater than or
equal to α.
Assuming additivity, Rosenbaum (2002a) refines this process to include covariates. Let
X be a matrix of measured covariates known to be associated with Y , but not including Z.
Under H0 : δ = τ0, let ˜(Y + Zτ0) = ˜(y(0)) = e be the residuals from some model of y(0)
as a function of X. Let qe be the ranks of e. Under the null H
0 : δ = τ0, the quantities y(0)
and X are fixed as they do not depend on Z. Thus, under the null, the Wilcoxon rank-sum
statistic, q′eZ, follows the same distribution described in the previous paragraph. A p-value
can be found to test the plausibility of this hypothesis in the same manner as before, and
a 1 − α confidence interval for τ assuming additivity follows analogously. This procedure
eliminates some of the variation in responses due to the covariates as e is expected to be less
dispersed than y(0).
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1.5.2 Propensity Score Matching
In a non-randomized study, e.g. an observational study, important covariates may not be
balanced across the vaccine and treatment group. Rosenbaum and Rubin (1983) introduced
the propensity score, or the probability of being assigned to treatment given all relevant co-
variates, as a method to adjust for unbalanced covariates in an observational study. They
proved that stratifying on the propensity score can lead to unbiased estimates of the treat-
ment effect under strong ignorability, the assumption that potential outcomes and treatment
assignment are independent given relevant group and individual level covariates
Pr[Zi = zi|Xi, yi(.)] = fZi|Xi(zi|Xi) (1.1)
in which Zi denotes the assignment of treatments in group i, yi() the potential outcomes in
group i, and Xi the relevant covariates in group i.
Under strong ingnorability, Hong and Raudenbush (2006) use propensity scores to approx-
imate a two-stage experiment using observational data. In the first stage, they use propensity
scores to classify schools as low retention or high retention. In the second stage, the propen-
sity score is used within high retention schools to separate students into seven strata based
on their individual propensities to be retained.
1.5.3 Inverse Probability Weighting
Consider an observational study examining the impact of an exposure (yes/no) on an
outcome (yes/no) that assumes no interference. Suppose we observe the data in Table 1.3.
In evaluating the effect of the exposure, our interest lies in the parameter τ =
∑n
j=1{yj(0)−
yj(1)}, the sample average causal effect. As the outcome is binary, τ ∈ [−1, 1], where values
close to 1 indicate significant preventive effects, values close to 0 indicate no effect, and values
close to -1 indicate harm. Inference on τ can be accomplished using the following inverse
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Table 1.3: Example exposure and outcome data for 8 individuals where τ = 0. Observed data
in the potential outcome structure are bolded.
yj(0) yj(1) Yj Zj Xj Pˆr[Zj = z|Xj ]
1 1 1 0 10 0.73
1 1 1 0 9 0.68
1 1 1 0 10 0.73
0 0 0 0 2 0.25
1 1 1 1 3 0.69
0 0 0 1 10 0.27
0 0 0 1 2 0.75
0 0 0 1 3 0.69
probability weighted (IPW) estimator:
τˆ IPW =
1
n
n∑
j=1
1{Zj = 0}Yj
Pr[Zj = 0]
− 1
n
n∑
j=1
1{Zj = 1}Yj
Pr[Zj = 1]
(1.2)
It is straightforward to show that τˆ IPW is unbiased, as
E[τˆ IPW ] =
1
n
n∑
j=1
E
[
1{Zj = 0}Yj
Pr[Zj = 0]
]
− 1
n
n∑
j=1
E
[
1{Zj = 1}Yj
Pr[Zj = 1]
]
=
1
n
n∑
j=1
Pr[Zj = 0]yj(0)
Pr[Zj = 0]
− 1
n
n∑
j=1
Pr[Zj = 1]yj(1)
Pr[Zj = 1]
= τ (1.3)
One of the key strong points of a randomized trial is that Pr[Zj = z] is known in advance,
so that for example if individuals are randomized with probability 1/2 to exposure, then
τˆ IPW =
∑n
j=1(1−Zj)Yj/(n/2)−
∑n
j=1 ZjYj/(n/2), the familiar difference in proportions. In
an observational study, Pr[Zj = z] is rarely known, and must be estimated. If one is willing
to invoke strong ignorability, i.e., the assumption in (1.1), then Pr[Zj = z|Xj ] can be used in
place of Pr[Zj = z] in τˆ
IPW . The intuition here is that Pr[Zj = z|Xj ] adjusts for situations
where individuals with certain X values are more likely to have Z = z, for example individuals
closer to a town could be more likely to have access to a bed net. For individual i = 1, ..., n,
Pr[Zj = z|Xj ] can be estimated using a statistical model, e.g., logistic regression.
The model predicted probabilities, Pˆr[Zj = z|Xj ] are displayed in Table 1.3. Using
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Pˆr[Zj = z|Xj ] in the denominators in (4.4), τˆ IPW = 0.34. If we had naively assumed
Pr[Zj = z|Xj ] = 1/2 for all i, τˆ IPW = 0.5. The naive estimate is biased, but the IPW
estimator offers an improvement toward the true τ = 0.
1.6 Interference
In the motivating example, it is clear that the outcome of individual j in group i (disease)
is dependent upon zi (vaccine status of other members of the bari) as well as zij (individual
vaccine status), i.e., interference is present. In addition to infectious diseases, interference is
found in other settings. Hong and Raudenbush (2006) investigated the effect of kindergarten
retention programs on math and reading test scores in those retained and those promoted to
first grade. “Peer effects” (interference) are hypothesized to be present because it is plausible
that a child promoted to first grade may flourish more in a learning environment in which low
achieving potential classmates have been retained in kindergarten. Peer effects are also found
in college roommates’ grade point averages and decisions to join a fraternity (Sacerdote, 2001).
Sobel (2006) examined neighborhood effects in the Moving to Opportunity study, a housing
mobility experiment sponsored by the U.S. Department of Housing and Urban Development
in which eligible ghetto residents in five U.S cities are randomly assigned to receive (or not)
various forms of assistance to relocate. Interference is present because a household’s decision
to move or not may be influenced by whether or not their neighbors receive a housing voucher
to move. Rosenbaum (2007) gives other detailed examples of experiments where interference
is possible.
If interference is unrestricted, the set {yij(z) : z ∈ Z} may contain up to 2n elements,
rendering inference impracticable. A scientifically reasonable assumption in many settings
is that interference can only occur between individuals in the same group (Halloran and
Struchiner, 1991, 1995), i.e., the outcome yij is only dependent on zi, the ni dimensional
vector of treatment assignments in group i. Sobel (2006) called this a partial interference
assumption. Under this assumption, the potential outcomes of individual j in group i can be
denoted by {yij(z) : z ∈ Zi}, where Zi is the set of 2ni realizations of the randomly assigned
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treatment vector in group i, Zi.
Hudgens and Halloran (2008) defined estimands of interest in the presence of partial
interference, specifically in the context of a two-stage randomized vaccine intervention to
prevent disease. The concepts easily generalize to other two-stage randomized experiments.
In the first stage, treatment strategies are randomized to groups, and in the second stage,
individuals are randomized to treatment or no treatment based on the strategy of the group.
An example could be that α1 is the strategy where half of a group is randomized to treatment
and α0 is the strategy where one third of a group is randomized to treatment. The presence
of two strategies introduces the idea of a direct and indirect effect of treatment. A direct
effect of treatment is the effect of treatment within a given strategy. An indirect (spillover)
effect is the effect of one strategy relative to another in the controls.
Average potential outcomes summarize the set of potential outcomes for each individual.
Let the average potential outcome for individual j on treatment z = 0, 1 in group i under
treatment strategy αs, s = 0, 1 be defined as
y¯ij(z;αs) ≡
∑
ω∈Rni−1
yij(zij = z, zi(j) = ω) Pr
s
(Zi(j) = ω|Zij = z) (1.4)
where zi(j) represents the vector of the ni−1 treatment assigments for all individuals in group
i except for individual j, and Rni−1 is the set of all vectors of length ni − 1 composed of 1s
and 0s. Let y¯i(z;αs) ≡
∑ni
j=1 y¯ij(z;αs)/ni be the average potential outcome in group i for
treatment assignment z under treatment strategy αs. Let y¯(z;αs) =
∑k
i=1 y¯i(z;αs)/k be the
population average potential outcome for treatment assignment z under treatment strategy
αs.
Additionally, define the average potential outcome for individual j in group i on treatment
strategy αs as
y¯ij(αs) ≡
∑
ω∈Rni
yij(zi = ω) Pr
s
(Zi = ω) (1.5)
so that the average potential outcome in group i under treatment strategy αs is y¯i(αs) ≡∑ni
j=1 y¯ij(αs)/ni, and the population average potential outcome under treatment strategy αs
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is y¯(αs) ≡
∑k
i=1 y¯i(αs)/k.
Given the definitions of the average potential outcomes above, Table 1.4 sums up the
targets of inference at the individual, group, and population levels.
Table 1.4: Causal effects at the individual, group, and population level
Level
Causal Effect Individual Group Population
Direct y¯ij(0;αs)− y¯ij(1;αs) y¯i(0;αs)− y¯i(1;αs) y¯(0;αs)− y¯(1;αs)
Indirect y¯ij(0;α0)− y¯ij(0;α1) y¯i(0;α0)− y¯i(0;α1) y¯(0;α0)− y¯(0;α1)
Total y¯ij(0;α0)− y¯ij(1;α1) y¯i(0;α0)− y¯i(1;α1) y¯(0;α0)− y¯(1;α1)
Overall y¯ij(α0)− y¯ij(α1) y¯i(α0)− y¯i(α1) y¯(α0)− y¯(α1)
Hudgens and Halloran (2008) derived unbiased estimators for the group and population
level effects in Table 1.4 in a completely randomized experiment. In a completely randomized
experiment, exactly mi of ni individuals are randomized to treatment in the second stage,
where mi is determined by the treatment strategy a group receives in the first stage. Let R
ni
mi
denote the set of vectors zi composed of exactly mi 1s and ni −mi 0s.
Hudgens and Halloran (2008) showed that estimators of the variances of the unbiased
estimators do not exist without further assumptions. They derived variance estimators that
are unbiased if causal effects are additive and are positively biased under the assumption of
stratified interference. Stratified interference assumes that an individual’s potential outcome
on treatment z ∈ {0, 1} is the same as long as a fixed number of other members in the group
are assigned treatment, or that
yij(zi) = yij(z
′
i) for all zi, z
′
i ∈ Rnimi such that zij = z′ij (1.6)
The assumption in (3.5) is plausible in a wide range of settings. Liu and Hudgens (2014)
identify conditions necessary to apply the parameter estimators and variance estimators of
Hudgens and Halloran (2008) to form large-sample 1 − α confidence intervals for the four
population level effects in Table 1.4.
Other approaches have also been taken for statistical inference with interference. Rosen-
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baum (2007) extends the covariance adjustment procedures to interference by comparing the
observed data to what would have happened in a uniformity trial on the same group of sub-
jects. A uniformity trial is an experiment in which all individuals receive placebo. The target
of inference is the unobserved random variable F , the number of times that treated responses
exceed control responses in the actual experiment but not the uniformity trial minus the
number of times that treated responses exceed control responses in the uniformity trial but
not in the actual trial. F measures whether or not in an experiment with interference there
is a greater tendency for treated subjects to have higher responses than controls than would
have been seen in a uniformity trial with no effect. An upper 1− α confidence interval for F
is found using the fact that F can be decomposed into the difference of two Mann-Whitney
statistics; one for the actual trial, T , and one for a uniformity trial, T˜ . The key observation
is that the distribution of T˜ is known because the null hypothesis of no effect is true in the
uniformity trial.
This method is extended to incorporate baseline covariate information following similar
logic to Rosenbaum (2002a). Let ˜(Y +Zτ0) = ˜(y(0)) = e be the residuals from some model
of y(0) as a function of X. The residuals e are used in the computation of the ranks in the
Mann-Whitney statistic from the actual trial, Te. An upper 1 − α confidence interval for F
follows in the same manner as in the previous paragraph.
For a two-stage randomized trial that assumes partial interference, Tchetgen Tchetgen
and VanderWeele (2012) derived exact confidence intervals for the four effects of interest.
In an observational study, they use inverse probability weighted (IPW) estimators to derive
unbiased estimators of the four population effects in Table 1.4. Specifically, assuming that
for s = 0, 1, pii(zi;αs) =
∏ni
j=1 α
zij
s (1 − αs)1−zij , for z = 0, 1 is the mechanism by which
individuals in group i are randomized to treatment, let
Yˆ ipwi (z;αs) =
∑ni
j=1 pii(Zi(j);αs)1{Zij = z}Yij(Zi)
ni × fZi|Xi(zi|Xi)
(1.7)
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and
Yˆ ipwi (αs) =
∑ni
j=1 pii(Zi;αs)Yij(Zi)
ni × fZi|Xi(zi|Xi)
(1.8)
Assuming strong ignorability (1.1), and that Pr[Zi = zi|Xi] > 0 for all zi ∈ Zi, they show that
Yˆ ipwi (z;αs) is an unbiased estimator of yi(z;αs) and that Yˆ
ipw
i (αs) is an unbiased estimator
of yi(αs), and thus that k
−1∑k
i=1{Yˆ ipwi (0;αs)− Yˆ ipwi (1;αs)} is an unbiased estimator of the
population direct effect of treatment strategy αs, k
−1∑k
i=1{Yˆ ipwi (0;α0)− Yˆ ipwi (0;α1)} is an
unbiased estimator of the population indirect effect, k−1
∑k
i=1{Yˆ ipwi (0;α0) − Yˆ ipwi (1;α1)} is
an unbiased estimator of the population total effect, and k−1
∑k
i=1{Yˆ ipwi (α0)− Yˆ ipwi (α1)} is
an unbiased estimator of the population overall effect. In observational studies, fZi|Xi(zi|Xi)
is rarely known, and must be estimated, e.g., by mixed effects logistic regression. Perez-
Heydrich et al. (2014) study the asymptotic properties of the estimators in (1.7) and (1.8)
when the propensity score is estimated, and apply them to the aforementioned cholera data
in Bangladesh.
Bowers et al. (2013) use a parametric model to reveal the unobserved potential outcomes.
They encourage researchers to write down their own models and they provide an inferential
algorithm. Model parameters θ are chosen to have meaning in the context of interference.
Each value of θ generates a hypothesis that can be tested by a p-value found using principles
of randomization based inference. A 1−α confidence interval for θ is formed by those values
of θ with p-values greater than or equal to α.
For illustration, let z denote any possible n×1 vector realization of the random treatment
assignment vector Z for z ∈ Z, where Z denotes the set of all possible treatment assignment
vectors. In each vector z, zi = 1 if individual i receives treatment and zi = 0 if individual i
receives control for i = 1, ..., n. Let Z = 0 denote the vector where all individuals are assigned
control, or a uniformity trial in the language of Rosenbaum (2007). Let y(z) denote the n× 1
vector of potential outcomes for randomization z, and let yi(z) denote the i
th element of y(z)
for i = 1, ..., n. Now, posit a model that transforms potential outcomes in a uniformity trial
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to the potential outcomes revealed by any randomization z ∈ Z:
yi(z) = {β + (1− zi)(1− β)exp(−τ2z′Si)}yi(0) (1.9)
in which Si is the i
th row of S, an n × n adjacency matrix where Sij = 1 if units i and j
are linked and 0 otherwise, and θ = (β, τ). In (1.9), {β + (1 − zi)(1 − β)exp(−τ2z′Si)} can
be thought of as the multiplicative effect of treatment program z on subject i’s potential
outcome in a uniformity trial in the presence of interference. If zi = 1, this multiplicative
effect simplifies to β, the direct effect of treatment. If zi = 0, this multiplicative effect is a
function of β and τ , a parameter measuring the spillover effect. If τ = 0, then individuals
with zi = 0 have a multiplicative effect of 1, or do not receive any benefit from treatment. The
quantity z′Si is the number of connections individual i has to other members in the group.
The experiment assigns Z = z˜, and thus reveals the potential outcome vector y(z˜). As-
suming (1.9), yi(0) = {β + (1 − z˜i)(1 − β)exp(−τ2z˜′Si)}−1yi(z˜) for i = 1, ..., n and thus we
can generate any yi(z) for z ∈ Z as
yi(z) = {β + (1− zi)(1− β)exp(−τ2z′Si)}{β + (1− z˜i)(1− β)exp(−τ2z˜′Si)}−1yi(z˜) (1.10)
for i = 1, ..., n for any z ∈ Z. Hypotheses about β and τ can be tested using randomization
based inference as follows. Under any null hypothesis, all potential outcomes are generated
by (1.10). A test statistics T is chosen such that its absolute value is large when treated
and control outcome distributions are different and small when treated and control outcome
distributions are similar. Examples of choices for T include the difference in means, differences
in sums of ranks, or the Kolmogorov-Smirnov test statistic. To measure the extremeness of
the observed data under this null hypothesis, compute the p-value as
p(β,τ) =
∑
z∈Z
1{|T (z, y(z))| ≥ |T obs|}/|Z| (1.11)
where |Z| is the number of elements in Z and T obs = T (z˜, y(z˜)). The hypothesis is rejected if
p(β,τ) is less than α. Following the standard procedure of inverting a test, 1 − α confidence
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sets for β and τ are composed of all values of β and τ for which p(β,τ) is greater than or equal
to α.
Toulis and Kao (2013) estimate causal peer influence effects using a frequentist and a
Bayesian procedure. In their language, individual i = 1, ..., N is a member (node) of the
vertex set in the network. For each individual i, there are ni = |Ni| neighboring nodes
who can influence Yi, the outcome of interest, where Ni is the set of all neighboring nodes.
Let Zi denote the treatment assignment of individual i, and let the vector Z denote the
treatment assignments of all individuals in the network. The potential outcome of individual
i under treatment Z is Yi(Z) ≡ Yi(Zi, Z(i)), where Z(i) is the vector of treatment assignments
excluding individual i. It is clear from the structure of the network that Yi(Z) is equal
to Yi(Zi, ZNi), where ZNi are the treatment assignments for the neighboring nodes. Let
Yi(0) ≡ Yi(Zi = 0, ZNi = 0). The causal estimand of primary effects is
η ≡ N−1
N∑
i=1
{Yi(1, ZNi = 0)− Yi(0)} (1.12)
The causal estimand of k-level peer effects is
δk ≡ |Vk|−1
∑
i∈Vk
(ni
k
)−1 ∑
z∈Z(Ni,k)
Yi(0, z)− Yi(0)
 (1.13)
where Vk is the set of all nodes that have at least k neighbors, or the set {i : ni ≥ k},
and Z(Ni, k) is the set of all assignments for nodes Ni in which exactly k receive treatment.
Additionally, they define estimands of “insulated neighbors” and “non-insulated neighbors”
which involve shared neighbors between nodes. In the Bayesian linear model approach for
inference on (1.12) and (1.13), consider a linear model for the individual potential outcomes:
Yi(Z) = µ+ τZi + γa
′
iZ + i (1.14)
where ai is the i
th column vector of the adjacency matrix A that summarizes links between
units such that Aij = 1 if units i and j are linked and 0 otherwise, and it is assumed that the
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N × 1 vector  ∼ N(0, σ2I) is independently and identically distributed noise. Let S = A′Z
be the N × 1 vector that summarizes the amount of exposure to peer influence for each node.
Under (1.14), the causal estimand of primary effects is
η = N−1
∑
i
[Yi(1, z = 0)− Yi(0)]
= N−1
∑
i
τ = τ (1.15)
and the causal estimand of k-level peer effects is
δk = |Vk|−1
∑
i∈Vk
(ni
k
)−1 ∑
z∈Z(Ni,k)
Yi(0, z)− Yi(0)

= |Vk|−1
∑
i∈Vk
(ni
k
)−1 ∑
z∈Z(Ni,k)
Si(z)γ

= kγ|Vk|−1
∑
i∈Vk
Wi ∝ γ (1.16)
The authors describe a Bayesian hierarchical model for inference on τ and γ which in turn
leads to inference on η and δk.
1.7 Bayesian Causal Inference
Rubin (1978) investigated the role of randomization in Bayesian inference for causal effects.
In this view, potential outcomes are no longer fixed, but are considered random variables.
Inference on causal parameters will be accomplished by modeling the missing potential out-
comes as a function of covariates, revealed potential outcomes, and parameters. Inference on
causal parameters is carried out by posterior distributions rather than confidence intervals.
There are no hypothesis tests to invert.
For illustration, consider Y (0), and Y (1), now random variables, as the potential out-
comes of interest, and let X be the covariates and θ the parameters. Following Rubin
(1978), Bayesian causal inference proceeds by specifying a joint distribution of all observ-
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able quantities, Pr[Y (0), Y (1), Z,X|θ], reasonable priors for θ, and treating the analysis as
a missing data problem. The missing values of interest are the missing potential outcomes,
Y mis = Z ′Y (0) + (1 − Z)′Y (1). It is typical that the joint distribution is factored into two
important distributions:
Pr[Y (0), Y (1), Z,X|θ] = Pr[Y (0), Y (1), X|θ] Pr[Z|Y (0), Y (1), X, θ] (1.17)
where Pr[Y (0), Y (1), X|θ] is a model of “the science” and Pr[Z|Y (0), Y (1), X, θ] is the as-
signment mechanism. If the assignment mechanism is unconfounded and ignorable as in
(1.1), then Pr[Z|Y (0), Y (1), X] = Pr[Z|X]. This assumption is common in many observa-
tional studies. After specifying the necessary inputs, samples are taken from the posterior
distribution of the causal effect using a Gibbs sampler.
1. Sample initial guesses for θ from the prior f(θ).
2. Sample values for Y mis conditional on θ from f(Y mis|Y obs, Xobs, Z, θ). Causal effects
that are functions of Y , e.g., n−1
∑
i{Yi(0)− Yi(1)}, can be recorded.
3. Sample values for θ from f(θ|Y obs, Y mis, Xobs, Z), i.e., conditional on the sampled Y mis
in step 2. Causal effects that are functions of θ, e.g., E[Y (0)]−E[Y (1)], can be recorded.
Bayesian inference for causal effects is flexible in the sense that the finite or superpopulation
persective can be adopted.
Applications of Bayesian causal inference abound. Chib and Hamilton (2000) used Bayesian
causal inference for clustered data. Dawid (2000) uses Bayesian decision analysis for causal
inference. Schwartz et al. (2011) put forth a Bayesian approach for causal inference on inter-
mediate variables. Crowley et al. (2014) perform a Bayesian causal analysis on the effects of
Haloperidol in paired mice where SUTVA is an untenable assumption.
To our knowledge, the literature on Bayesian methods for causal inference in the presence
of interference is limited. Toulis and Kao (2013) estimate causal peer influence effects using
a frequentist and a Bayesian procedure.
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1.8 Summary of Research
In the first paper, two exact confidence intervals are derived for the group and popula-
tion direct effects under no interference when the outcome is binary, as in a vaccine trial.
Rosenbaum (2001) provided a key ingredient, attributable effects, to be used in the creation
of one of the exact confidence intervals. The other exact confidence interval makes use of the
permutation test strategy outlined above for Table 1.2.
In the second paper, exact confidence intervals are developed for the population direct,
indirect, total, and overall effects in a two stage randomized trial that assumes stratified
interference. These methods will be contrasted with the exact confidence intervals for the four
effects of Tchetgen Tchetgen and VanderWeele (2012) in the presence of stratified interference.
In the third paper, a Bayesian approach is proposed for inference on causal parameters
in observational data where interference is present. The motivating data arise from the 2007
Demographic and Health Survey in the Democratic Republic of the Congo, an observational
study. In the Messina et al. (2011) analysis, 7746 individuals in 300 communities with com-
plete individual and community covariate and outcome data were included in a multilevel
statistical model. The group level parameter for bed net use on malaria outcome was statisti-
cally significant, whereas the analagous individual level parameter was not. In a re-analysis of
these data, Bayesian methods are developed for inference on the population direct, indirect,
total, and overall effect of bed net use on malaria outcome.
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CHAPTER 2: RANDOMIZATION INFERENCE FOR TREATMENT
EFFECTS ON A BINARY OUTCOME
2.1 Introduction
In many settings inference is desired about the effect of a treatment relative to the absence
of treatment on a particular outcome. In studies where treatment is randomly assigned, ran-
domization based inference can be employed to draw conclusions about the effect of treatment.
For instance, when the outcome is continuous, randomization based confidence intervals can
be formed using the classic approach of Hodges and Lehmann (1963). In addition to ran-
domization, this approach relies on one particular key assumption, namely that the effect of
treatment is additive, i.e., the same for all individuals. Additivity is a strong assumption that
may not hold in many settings, particularly if the outcome is binary (LaVange et al., 2005).
In this paper, two methods are developed for constructing randomization based confidence
sets for the average effect of treatment on a binary outcome without assuming additivity.
These sets are formed by (i) combining prediction sets for attributable effects (Rosenbaum,
2001), and by (ii) inverting a permutation test.
Specifically, consider a study in which m of n individuals are randomized to treatment
and subsequently a binary outcome is measured. Let the binary outcome of interest be
denoted by Yj where Yj = 1 if the event occurs and 0 otherwise for individuals j = 1, . . . , n.
Let treatment assignment be indicated by Zj where Zj = 1 if treatment and 0 if placebo.
Prior to treatment assignment, assume each individual has two potential outcomes: yj(1)
if assigned treatment, and yj(0) if placebo (or control). After treatment assignment, one
of the two potential outcomes is observed so that the observed outcome for individual j is
Yj = Zjyj(1) + (1 − Zj)yj(0). Let Z denote the vector of treatment assignments, Y denote
the vector of observed outcomes, and y(z) denote the vector of potential outcomes when
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all n individuals are assigned z ∈ {0, 1}. Define the treatment effect for individual j to be
δj = yj(1)− yj(0), so that δj = 1 if treatment causes event, 0 if treatment has no effect, and
−1 if treatment prevents event. Let δ = y(1)−y(0) be the vector of treatment effects, and let
τ =
∑
δj/n be the average treatment effect, where here and in the sequel
∑
=
∑n
j=1. Our
goal is to construct a confidence set for τ .
In both of the methods to follow, inference on δ will be used as a starting point for
inference on τ . Prior to seeing the data, δ ∈ {−1, 0, 1}n, a set with 3n elements. Once the
data are observed, one of the two potential outcomes is revealed and one is missing. Because
the missing outcome is known to equal 0 or 1, once the data are observed δj is restricted to
take one of two values for each individual j, such that there are only 2n δ vectors compatible
with the observed data. Similarly, prior to observing the data, the parameter τ can take on
values in {−n/n, . . . , 0/n, . . . , n/n}, a set with 2n+ 1 elements of width two, where here and
in the sequel we define the width of a set to be the difference between the maximum and
minimum values of the set. After observing the data, it can be easily shown that the set of
compatible τ values is
{∑
Yj(2Zj − 1)−m
n
,
∑
Yj(2Zj − 1)−m+ 1
n
, . . . ,
∑
Yj(2Zj − 1)−m+ n
n
}
(2.1)
a set with n+ 1 elements of width one. Each of the 2n compatible δ vectors maps to one of
these n+ 1 compatible τ values. The data are informative in the sense that n of the possible
τ values can be rejected (with type I error zero). On the other hand, the null τ value of 0 will
always be contained in the set of compatible τ values. This is analogous to a well known result
about “no assumption” large sample treatment effect bounds (Manski, 1990). The methods
below construct confidence sets for τ that are subsets of the set (4.9) and thus potentially of
width less than one.
The two proposed methods are similar in spirit to the classic Hodges-Lehmann confidence
interval in that randomization-based tests are inverted to construct the confidence sets. How-
ever, unlike the Hodges-Lehmann approach, no assumption is made that the effect is additive.
This is critical because in many settings it will be unlikely or implausible that the treatment
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effect is the same for all individuals. For example, to assume δj = 1 for all j corresponds
to the scenario yj(1) = 1 and yj(0) = 0 for all j, i.e., everyone has an event if and only if
treated. Moreover, this particular additivity assumption could be rejected with type I error
zero if Yj = 0 for at least one individual assigned treatment or Yj = 1 for at least one indi-
vidual assigned placebo. An analogous statement applies to the assumption that δj = −1 for
all j.
The two proposed methods rely on the randomization-based mode of inference wherein the
n individuals are viewed as the finite population of interest and probability arises only through
the randomization assignment to treatment or placebo (Rosenbaum, 2002b, chap. 2). The
randomization-based approach to inference has several appealing properties. For example,
the resulting inferences are exact without relying on distributional assumptions and do not
require large sample approximations. Randomization-based inference also does not require
the observed data constitute a random sample from some infinite population, unlike the more
common superpopulation model (Robins, 1988). This is important in settings where assuming
random sampling from the target population may be dubious. For example, individuals who
volunteer to participate in a clinical trial may be a biased sample from the general population.
Similarly, animals or organisms in a laboratory experiment may differ fundamentally from
their counterparts in nature. See Rosenbaum (2002b); Robins (1988); Miettinen and Cook
(1981); Rubin (1991); Lehmann (1998) for additional discussion related to the various modes
of inference for treatment (i.e., causal) effects.
The outline of the rest of this paper is as follows. In Section 2, an approach for finding a
confidence set for τ based on attributable effects (Rosenbaum, 2001) is proposed. In Section 3,
a confidence set for τ is found by inverting a permutation test. In Section 4 the two proposed
confidence sets are compared with a large sample confidence interval for τ (Robins, 1988)
as well as the usual Wald confidence interval and a commonly used exact interval for the
difference in binomial proportions; the different confidence intervals (or sets) are evaluated
in simulation studies and illustrated using data from a vaccine adherence trial. In Section 5,
extensions to settings with more than one group are considered. Section 6 concludes with a
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discussion.
2.2 Attributable Effect Sets
This section describes how a 1− α confidence set for τ can be constructed by combining
prediction sets for attributable effects (Rosenbaum, 2001). The observed data {Z, Y } can
be displayed in traditional 2 × 2 form as in Table 2.1. Noting that ∑ZjYj = ∑Zjyj(1),∑
Zj(1−Yj) =
∑
Zj(1−yj(1)),
∑
(1−Zj)Yj =
∑
(1−Zj)yj(0),
∑
(1−Zj)(1−Yj) =
∑
(1−
Zj)(1− yj(0)), and yj(1) = yj(0) + δj , Table 2.1 can be re-expressed as a function of Z, y(0),
and A1(Z, δ) =
∑
Zjδj , the attributable effect of treatment in the treated (Rosenbaum, 2001),
as shown in Table 2.2. In words, A1(Z, δ) =
∑
Zjyj(1) −
∑
Zjyj(0) is the difference in the
number of events which occurred in the treated subjects and the number of events that would
have occurred if, contrary to fact, they had been exposed to control instead. After observing
the data, it can be inferred that A1(Z, δ) ∈ {∑ZjYj−m,∑ZjYj−m+ 1, . . . ,∑ZjYj}, a set
with m+1 elements. The observed data can be used to construct a prediction set for A1(Z, δ).
We refer to these sets as prediction sets rather than confidence sets because A1(Z, δ) is a
random variable rather than a parameter. Rosenbaum (2001) described how to construct such
prediction sets. In particular, consider testing H0 : δ = δ
0 for some compatible vector of effects
δ0. Under H0, subtracting A
1(Z, δ0) from the (1,1) cell of Table 2.2 and adding A1(Z, δ0) to
the (1,2) cell creates a table with fixed margins, as the row margins of this “adjusted” table are
fixed by design and the column margins are fixed because
∑
yj(0) does not depend on Z. Let
U =
∑
ZjYj − A1(Z, δ) =
∑
Zjyj(0) denote the number of events in the treated individuals
had, contrary to fact, they not been treated. Note U is pivotal because its distribution
under H0 does not involve δ
0, i.e., U follows a hypergeometric distribution with Pr(U = u)
=
(∑
yj(0)
u
)(
n−∑ yj(0)
m−u
)/(
n
m
)
for u ∈ {max{0,m + ∑ yj(0) − n}, . . . ,min{∑ yj(0),m}}. Let
u(δ0) =
∑
ZjYj − A1(Z, δ0), the value of U under H0, and let the two-sided Fisher’s exact
test p-value be pδ0(Z, Y ) =
∑
u Pr(U = u)1{Pr(U = u) ≤ Pr(U = u(δ0))}. Note each of
the 2n compatible δ0 corresponds to one of the m+ 1 compatible A1(Z, δ0). Therefore, those
δ0 that map to the same value of A1(Z, δ0) will all yield the same p-value when testing H0.
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Let P(A1(Z, δ)) = {A1(Z, δ) : pδ(Z, Y ) ≥ α} denote the set of compatible attributable effects
of treatment in the treated where the null H0 : δ = δ
0 is not rejected at significance level
α. The set P(A1(Z, δ)) is a 1− α prediction set for A1(Z, δ) in the sense that Pr[A1(Z, δ) ∈
P(A1(Z, δ))] ≥ 1− α.
Similarly, define the attributable effect of treatment in the untreated as A0(Z, δ) =
∑
(1−
Zj)δj . In words, A
0(Z, δ) =
∑
(1−Zj)yj(1)−
∑
(1−Zj)yj(0) is the difference in the number
of events in the control subjects had, contrary to fact, they been treated and the number of
events actually observed in the control subjects. After observing the data, it can be inferred
that A0(Z, δ) ∈ {−∑(1−Zj)Yj ,−∑(1−Zj)Yj + 1, . . . ,−∑(1−Zj)Yj + n−m}, a set with
n−m+1 elements. A 1−α prediction set can be constructed for A0(Z, δ) in the same fashion
as for A1(Z, δ). While the attributable effects A1(Z, δ) and A0(Z, δ) are random variables,
they are constrained in sum to equal a constant:
A1(Z, δ) +A0(Z, δ) =
∑
Zjδj +
∑
(1− Zj)δj =
∑
δj = nτ (2.2)
The relationship between the attributable effects and τ in (2.2) suggests combining prediction
sets for A1(Z, δ) and A0(Z, δ) to obtain a confidence set for τ . The following proposition
indicates that a confidence set for τ can be formed by combining prediction sets with a
Bonferroni type adjustment.
Proposition 2.1. If {L1, L1 + 1, . . . , U1} is a 1− α/2 prediction set for A1(Z, δ), where L1
is the minimum of the prediction set and U1 is the maximum, and {L0, L0 + 1, . . . , U0} is
a 1 − α/2 prediction set for A0(Z, δ), where L0 and U0 are defined similarly, then {(L1 +
L0)/n, (L1 + L0 + 1)/n, . . . , (U1 + U0)/n} is a 1− α confidence set for τ .
A proof of Proposition 2.1 is given in the Appendix. Constructing a confidence set for
τ as described in Proposition 2.1 only requires testing n + 2 hypotheses, as there are m + 1
compatible values of A1(Z, δ0) that must be tested and there are n−m+ 1 compatible values
of A0(Z, δ0) that must be tested. Thus the attributable effect based confidence set for τ is
computationally feasible even for large n; this is in contrast to the permutation test approach
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described next.
Note Proposition 2.1 relies on a Bonferroni type adjustment. Because A1(Z, δ) and
A0(Z, δ) are constrained according to (2.2), it might be tempting to instead add the lower
and upper bounds of two 1 − α prediction sets and divide by n (i.e., without a Bonferroni
type adjustment). However, such a naive approach is not guaranteed to provide coverage of
at least 1−α as demonstrated by the following example. Suppose an experiment is to be con-
ducted with m = 4 of n = 9 individuals to be assigned treatment. As each individual’s pair of
outcomes {yj(0), yj(1)} can take on 4 values, there are 49 possible sets of potential outcomes
for the finite population of individuals. Each of these sets maps to one of the 2n + 1 = 19
values of τ . Consider the subset of these 49 sets that map to τ = 1/9. For each of the sets
of potential outcomes in this subset, there are
(
n
m
)
possible observed data sets. Applying the
naive approach described above of combining two 95% prediction sets without a Bonferroni
adjustment to each of the possible observed data sets, only 92% of the sets contain τ = 1/9.
2.3 Inverted Permutation Test
A permutation based approach can also be employed to find a confidence set for τ . Prior
to specifying a null hypothesis H0 : δ = δ
0, each individual has one observed and one missing
potential outcome; however, under H0, both outcomes are known. A null hypothesis with
this property is considered sharp. If the missing outcome for individual j is yj(0), it is known
under the null to equal yj(1)− δ0j = Yj − δ0j , and if the missing outcome is yj(1), it is known
under the null to equal yj(0) + δ
0
j = Yj + δ
0
j . To determine how likely the observed data
are under H0, a test statistic can be chosen, its distribution under the null computed, and a
measure of extremeness of the observed data defined (Rubin, 1991§4.1). A natural choice for
the test statistic is the difference in observed means
T =
∑
ZjYj/m−
∑
(1− Zj)Yj/(n−m) (2.3)
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Neyman (1923) showed that T is an unbiased estimator of τ , i.e., E(T ) = τ , where the
expected value is taken over all possible hypothetical randomizations of m of the n individuals
to treatment under the true δ vector. The sampling distribution of T under the null can be
determined exactly by computing T for each of the C =
(
n
m
)
possible randomizations because
all potential outcomes are known under the sharp null H0. For randomization c = 1, . . . , C,
let tc denote the value of T under H0. Each randomization occurs with probability 1/C, so
the permutation test p-value is defined to be
∑C
c=1 1{|tc − τ0| ≥ |tobs − τ0|}/C where tobs is
the value of T for the observed data, and τ0 =
∑
δ0j /n. The subset of compatible δ
0 vectors
where the permutation test p-value is greater than or equal to α forms a 1−α confidence set
for δ. The τ0 values corresponding to the δ0 vectors in this confidence set for δ form a 1− α
confidence set for τ .
Although finding a confidence set for δ entails explicitly testing 2n hypotheses, finding a
confidence set for τ can be accomplished by testing only O(n4) hypotheses. To see this, let
nzy =
∑n
j=1 1{Zj = z, Yj = y} for z ∈ {0, 1} and y ∈ {0, 1}. For the n11 individuals with
Zj = 1 and Yj = 1, δj can be 0 or 1. Holding the δj value fixed for the other n10 + n01 + n00
individuals, for fixed v ∈ {0, 1, . . . , n11} all δ vectors with
∑
j:Zj=Yj=1
1{δj = 1} = v will lead
to the same τ value and permutation p-value, i.e., it is sufficient to test n11 + 1 hypotheses
about individuals with Zj = Yj = 1. Similar logic can be applied to the other three cross-
classifications of treatment and outcome, such that it is sufficient to test (n11 + 1)(n10 +
1)(n01 + 1)(n00 + 1) hypotheses to find a confidence set for τ .
As O(n4) becomes large, computing permutation confidence sets may become infeasible.
In addition to utilizing the compiler package (R Core Team, 2014), the following two strate-
gies may be employed to improve computational efficiency. First, rather than using all
(
n
m
)
possible randomizations to find the permutation p-value for each hypothesis being tested, a
Monte Carlo procedure based on a random sample of the randomizations can be employed to
approximate the p-value (Mehta and Patel, 2003). Second, the lower limit of the confidence
set for τ can be found as follows. Starting with the smallest compatible τ value, compute
the permutation p-value for each corresponding δ vector. If at least one p-value is greater
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than or equal to α, set the lower limit to this value of τ . Otherwise, repeat this process for
the next largest compatible τ value until a corresponding δ vector is found whose p-value
is greater than or equal to α. The upper limit can be found analogously starting with the
largest compatible τ value.
2.4 Illustrations
2.4.1 Simple Examples
In this section, the attributable effects and permutation confidence sets for τ are compared
with an asymptotic confidence interval for τ . Robins (1988) proposed the following large
sample (1− α) confidence interval for τ
T ± z(1−α/2){pˆ1(1− pˆ1)/m+ pˆ0(1− pˆ0)/(n−m) + Rˆ}1/2 (2.4)
where pˆ1 =
∑
ZjYj/m, pˆ0 =
∑
(1−Zj)Yj/(n−m), Rˆ = {(2pˆ0− pˆ1)(1− pˆ1)− pˆ0(1− pˆ0)}/n if
pˆ1 ≥ pˆ0, Rˆ = {(2pˆ1 − pˆ0)(1− pˆ0)− pˆ1(1− pˆ1)}/n if pˆ0 > pˆ1, and z(1−α/2) denotes the 1−α/2
quantile of a standard normal distribution. As n → ∞ with m/n → c ∈ (0, 1), the interval
(2.4) will contain τ with probability 1− α (Robins, 1988).
To compare the methods, consider an experiment with m = 4 of n = 8 individuals assigned
treatment. As each individual’s outcomes {yj(0), yj(1)} can take on 4 values, there are 48
possible sets of potential outcomes for the finite population of individuals. For each of these 48
sets, there are
(
n
m
)
possible observed data sets. For each of the 48
(
n
m
)
possible combinations of
potential outcomes and observed data sets, attributable effects and permutation confidence
sets and asymptotic confidence intervals were computed. Figure 2.1 displays the coverage
probability and average width for the three methods at each of the 2n + 1 = 17 values of τ
for α = 0.05. To illustrate how the points in Figure 2.1 were computed, consider the coverage
probability of the asymptotic confidence set for τ = −6/8 in the top panel of Figure 2.1.
Of the 48 = 65536 sets of potential outcomes, 120 have τ = −6/8. For these 120 sets of
potential outcomes, the asymptotic sets has coverage probability 0.79 for 28 of the sets, 0.71
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for 64 of the sets, and 0.79 for 28 of the sets, so the coverage probability for the asymptotic
confidence set at τ = −6/8 is the weighted mean, 0.75. The asymptotic confidence sets fail
to provide the desired 95% coverage for many τ values; on the other hand, the attributable
effects and permutation confidence sets provide the desired level of coverage for all τ values.
Permutation confidence sets have a smaller width than the attributable effects confidence sets
for each value of τ in this experiment.
2.4.2 Simulation Study
To further study the proposed methods, the permutation, attributable effects, and asymp-
totic approaches were compared to the usual Wald interval
T ± z(1−α/2){pˆ1(1− pˆ1)/m+ pˆ0(1− pˆ0)/(n−m)}1/2 (2.5)
and the Santner Snell (SS) exact confidence interval for a difference in binomial proportions
(Santner and Snell, 1980) in a series of simulation studies. The SS confidence interval is
the default exact method for a difference in binomial proportions in SAS 9.3 PROC FREQ
(SAS Institute Inc., 2014). While the Wald and SS methods do not assume additivity, both
assume (implicitly perhaps) that the observed data are a random sample from some larger
superpopulation. In particular, the Wald and SS methods suppose the numbers of events in
the treated and control groups are binomial random variables. As explained in §4 of Robins
(1988), this binomial model follows from assuming either (a) individual potential outcomes are
stochastic, Bernoulli random variables with equal mean across individuals, or (b) the treated
and control groups constitute a random sample from some larger superpopulation. Robins
argues the mean homogeneity assumption of (a) will usually be biologically implausible, and
therefore (b) is implicitly being assumed whenever the binomial model is employed.
Data were simulated under three scenarios: (i) a randomization model, (ii) a random-
ization model under varying degrees of additivity, and (iii) a superpopulation model. In all
simulations where
(
n
m
) ≥ 100, a random sample with replacement of 100 randomizations was
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used to approximate permutation test p-values.
Simulations for scenario (i), a randomization model, were carried out for fixed values of
n, m, and τ using the following steps:
0. Potential outcomes were generated by first letting yj(1) = 1 and yj(0) = 0 such
that δj = 1 for individuals j = 1, . . . , τn. Then for j = τn + 1, . . . , n, the poten-
tial outcome yj(1) was sampled from a Bernoulli distribution with mean 0.5. Finally
the potential outcomes yτn+1(0), . . . , yn(0) were set equal to a random permutation
of yτn+1(1), . . . , yn(1). Generating the potential outcomes in this fashion ensured the
average treatment effect equaled τ .
1. Observed data were generated by randomly assigning m individuals to treatment and
n−m individuals to control. Observed outcomes were then generated based on treatment
assignment and the potential outcomes from step 0.
2. All five 95% confidence intervals (or sets) were computed for the observed data generated
in step 2.
3. Steps 1-2 were repeated 1000 times.
The results for scenario (i) in Table 2.3 show that the permutation confidence set attained
the narrowest width on average among methods that maintained nominal coverage. For all
intervals (or sets) the average width decreased as τ increased for fixed n and percent assigned
treatment. For fixed n and τ , average width and coverage results were similar for 30%
treatment compared to 70% treatment. The asymptotic interval was strictly narrower than
the Wald interval, which is guaranteed (Robins, 1988). Coverage of the asymptotic interval
tended to be substantially less than the nominal level for τ = 0.95. For example, the coverage
of the asymptotic interval for 70% assigned treatment and τ = 0.95 was only 0.65 even when
n = 100.
Simulations for scenario (ii) were carried out similar to scenario (i) but with varying
degrees of additivity. In particular, as a measure of the amount of additivity let γ =
∑
j 1{δj =
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0}/n denote the proportion of individuals where the treatment has no effect, such that γ ∈
[0, 1], with the degree of additivity increasing as γ → 1. For fixed values of n, m, and
γ, simulations proceeded in the same manner as scenario (i) except that a different step
0 was used to generate potential outcomes. Specifically, for j = 1, . . . , γn, the potential
outcome yj(1) was randomly sampled from a Bernoulli distribution with mean 0.5 and yj(0)
was set equal to yj(1) such that δj = 0. For individuals j = γn + 1, . . . , (1 + γ)n/2, the
potential outcomes were set to yj(1) = 0 and yj(0) = 1 such that δj = −1. For individuals
j = (1+γ)n/2+1, . . . , n, the potential outcomes were set to yj(1) = 1 and yj(0) = 0 such that
δj = 1. Generating the potential outcomes in this fashion ensured the degree of additivity
equaled γ. The results for scenario (ii) in Table 2.4 show that the permutation confidence
set again attained the narrowest width on average among methods that maintained nominal
coverage. Coverage of the asymptotic interval tended to be less than the nominal level for
n ≤ 60 and γ = 1. For n = 100 the asymptotic interval nearly achieved the nominal level for
all nine combinations of m and γ.
Simulations were conducted under scenario (iii), a superpopulation model, as above but
with different steps 0 and 1. In particular, potential outcomes were not generated. Rather,
the observed outcome data were generated by first randomly assigning m of n individuals to
treatment. Outcomes were then independently sampled from a Bernoulli distribution with
mean p1 = 0.5 + ∆/2 for individuals assigned Z = 1 and from a Bernoulli distribution with
mean p0 = 0.5−∆/2 for individuals assigned Z = 0, where ∆ was some fixed value denoting
the difference in the probability of an event in the superpopulation when an individual receives
treatment compared to not receiving treatment. After generating observed data, all five 95%
confidence intervals (or sets) were computed. This process of data generation and interval (or
set) computation was repeated 1000 times, and average interval (or set) widths and coverages
were computed for the five approaches. The results for scenario (iii) in Table 2.5 show
that the SS confidence interval was the only method to achieve nominal coverage across all
simulation setups (with the exception of 30% assigned treatment at ∆ = 0.2 when n = 60).
The Wald confidence interval did not reliably achieve nominal coverage with ∆ = 0.95, an
unsurprising result given that the Wald confidence interval is known to cover poorly near
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the boundary of the parameter space (Agresti and Caffo, 2000). The asymptotic confidence
interval undercovered even with n = 100. The permutation and attributable effects confidence
sets performed well, albeit with some slight undercoverage. The permutation confidence set
tended to be as or more narrow than SS.
2.4.3 Vaccine Adherence Trial
In a study of adherence to the hepatitis B vaccine series (Seal et al., 2003), 96 injection
drug users were randomized to a monetary incentive group or an outreach arm. Of the 48
individuals in the monetary incentive group, 33 were adherent, and of the 48 in the outreach
arm, 11 were adherent. Using (2.3), T = 22/48, suggesting that 44 more individuals would
have been adherent to the hepatitis B vaccine series if all 96 individuals were given monetary
incentives compared to if no individuals received monetary incentives. The attributable effects
confidence set is contained in the interval [0.23, 0.64]. The permutation confidence set, found
using 100 re-randomizations for each hypothesis test, is contained in the interval [0.28, 0.64].
The SS, asymptotic, and Wald confidence intervals are [0.26, 0.63], [0.31, 0.60], and [0.28,
0.64] respectively. Thus for this example the permutation confidence set is the narrowest of
the three exact approaches. The permutation confidence set has the same width as the Wald
interval but is slightly wider than the asymptotic interval; however, unlike the Wald and
asymptotic intervals, the permutation confidence set is guaranteed to cover at the nominal
level.
2.5 Multiple Strata Designs and Observational Studies
The methods above can be extended to studies where stratified randomization is em-
ployed, i.e., individuals are randomized to treatment or control within strata. Assume that
in each of i = 1, . . . , k strata, mi of ni individuals are randomized to treatment. Assume
randomization is conducted independently across strata, such that there are
∏k
i=1
(
ni
mi
)
total
possible randomizations. For stratum i, let δij be the treatment effect for individual j and
let δi be the vector of treatment effects. Define Z analogously for stratum i such that Zij is
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the treatment assignment for individual j and Zi is the vector of treatment assignments. The
average treatment effect is τ =
∑
i
∑
j δij/n, where n =
∑k
i=1 ni and where here and below∑
i =
∑k
i=1 and
∑
j =
∑ni
j=1.
The permutation based approach becomes computationally unwieldy in this setting. The
computational burden of the permutation confidence set is based on the product of two factors.
The first factor is the number of hypotheses to test. For the one stratum setting, the number
of hypotheses to test is O(n4) whereas for the k-strata setting the number of hypotheses to test
is O(max{n1, ..., nk}4k). The second factor is the number of permutations needed to test each
hypothesis. In the one stratum problem, this number is
(
n
m
)
. In the k-strata case, the second
factor is
∏k
i=1
(
ni
mi
)
. Although for fixed n =
∑k
i=1 ni the second factor will be smaller for the k-
strata case, the first factor in the k-strata case will be much larger and therefore will dominate
the product. For example, suppose there are n = 100 individuals in k = 4 strata of equal
sample size such that n1 = · · · = n4 = 25; then max{n1, . . . , n4}4k = 2516 >> 1004 = n4.
Given these computational challenges, the attributable effects based approach may be
preferred in the multiple strata setting. To construct attributable effect based confidence
sets, first note under H0 : δ = δ
0, or equivalently that δi = δ
0
i for i = 1, . . . , k, the observed
data can be represented in a k-table analogue of Table 2.2. Under this null, subtracting the
attributable effect of treatment in the treated, A1i (Zi, δi) =
∑
j Zijδ
0
ij , from the (1,1) cell and
adding A1i (Zi, δi) to the (1,2) cell for stratum i = 1, . . . , k will serve to fix all row and column
margins in the k-table analogue of Table 2.2. As a result, the joint distribution of the cor-
responding pivotal quantities will be a product of independent hypergeometric distributions.
The hypothesis H0 : δ = δ
0 is rejected if the two-sided p-value resulting from a Cochran
Mantel Haenszel exact test is sufficiently small.
As in the single stratum setting considered in Section 2, this hypothesis test can be
inverted to obtain prediction sets for A1(Z, δ) and for A0(Z, δ). These prediction sets are
considerably more difficult to find in the k strata setting. As A1(Z, δ) =
∑
iA
1
i (Zi, δi), there
may be multiple combinations of A11(Z1, δ1), . . . , A
1
k(Zk, δk) that sum to the same value of
A1(Z, δ). Each combination producing the same A1(Z, δ) may lead to a different p-value. A
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value of A1(Z, δ) will be included in a 1 − α prediction set if the maximum p-value among
the combinations is greater than α. Finding the maximum p-value over the combinations of
A11(Z1, δ1), . . . , A
1
k(Zk, δk) that sum to the same value of A
1(Z, δ) is an integer programming
problem that can be solved using existing software, e.g., the R package rgenoud (Mebane Jr.
and Sekhon, 2011). Proposition 2.1 allows for the construction of a confidence set for τ in
the k strata setting also.
The methods in this section may have utility in observational studies where one is willing to
assume treatment selection is independent of potential outcomes conditional on some sufficient
set of covariates (i.e., there are no unmeasured confounders). In this setting, an observational
study can be envisaged as a stratified randomized trial performed by nature (Rosenbaum,
2002b§ 3.2), (Robins, 1988). With the strata formed by levels of the measured covariates,
these methods can be employed to find exact 1−α confidence sets for the effect of treatment
or exposure on a binary outcome.
2.6 Discussion
In this paper, we have presented two methods for constructing randomization based con-
fidence sets for the average effect of a treatment on a binary outcome without assuming
additivity. The first approach utilizes attributable effect sets (Rosenbaum, 2001); these sets
are adjusted using a Bonferroni correction and combined to form a confidence set. The sec-
ond method involves inverting a permutation test. Both methods are nonparametric, are
guaranteed to yield sets that have width no greater than one, require no assumptions about
random sampling from a larger population, and are exact in the sense that the probability of
containing the true treatment effect is at least 1− α. While the attributable effects method
is computationally fast and the permutation method is computationally slow as n increases,
simulations show that permutation method has smaller average width. Based on finite pop-
ulation simulation results, the permutation approach is recommended over the attributable
effects and asymptotic approaches for n ≤ 100. Additional simulation results (not shown)
indicate the asymptotic approach tends to provide nominal coverage for n > 100, although
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coverage may still be less than the nominal level for extreme values of τ (e.g., τ ≈ 1). Exten-
sions that allow for stratifying on categorical baseline covariates were also considered. The
R package RI2by2 is available on CRAN (Rigdon, 2014) for computing the attributable ef-
fects and permutation confidence sets as well as the asymptotic confidence interval in the one
stratum setting.
There are several possible future directions to this research. For example, one future
direction would be to increase the computational efficiency of the permutation based approach.
Both the permutation and attributable effects based confidence sets tend to be conservative in
that the empirical coverage in the simulation studies tended to be greater than the nominal
level. Therefore another future research direction could explore adaptations of these two
approaches which yield less conservative sets. For instance, techniques could be explored (as
in Thulin (2014)) such that the average coverage equals the nominal level, although such
procedures would no longer necessarily be exact.
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2.7 Tables and Figures
Table 2.1: Cross classification of observed counts of treatment Z and outcome Y
Y
1 0 Total
Z
1
∑
ZjYj
∑
Zj(1− Yj) m
0
∑
(1− Zj)Yj
∑
(1− Zj)(1− Yj) n−m∑
Yj
∑
(1− Yj) n
Table 2.2: Cross classification of observed counts of treatment Z and outcome Y as a function
of the potential outcomes yj(0) and the attributable effect A
1(Z, δ)
Y
1 0 Total
Z
1
∑
Zjyj(0) +A
1(Z, δ)
∑
Zj(1− yj(0))−A1(Z, δ) m
0
∑
(1− Zj)yj(0)
∑
(1− Zj)(1− yj(0)) n−m∑
yj(0) +A
1(Z, δ) n−∑ yj(0)−A1(Z, δ) n
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Table 2.3: Simulation results for scenario (i). Table entries give the empirical width [coverage]
of 95% confidence sets or intervals, where τ is the true average treatment effect, % treatment
is the percent of n total individuals assigned to treatment in each experiment, Perm is the
permutation confidence set, AE is the attributable effects confidence set, Asymptotic is the
asymptotic confidence interval in Robins (1988), Wald is the usual large sample interval for a
risk difference, and SS is the Santner-Snell Santner and Snell (1980) exact confidence interval.
30% treatment 50% treatment 70% treatment
n Method τ = 0.2 τ = 0.5 τ = 0.95 τ = 0.2 τ = 0.5 τ = 0.95 τ = 0.2 τ = 0.5 τ = 0.95
20 Perm 0.73[1.00] 0.70[0.99] 0.43[1.00] 0.75[1.00] 0.70[1.00] 0.34[1.00] 0.74[1.00] 0.70[0.99] 0.41[1.00]
AE 0.81[1.00] 0.76[1.00] 0.53[1.00] 0.88[1.00] 0.75[1.00] 0.52[1.00] 0.84[1.00] 0.76[1.00] 0.53[1.00]
Asymptotic 0.80[0.96] 0.68[1.00] 0.12[0.30] 0.76[0.96] 0.60[0.98] 0.11[0.49] 0.82[0.97] 0.67[0.91] 0.10[0.70]
Wald 0.87[0.97] 0.79[0.96] 0.14[0.30] 0.83[0.99] 0.73[0.98] 0.14[0.49] 0.89[0.98] 0.79[0.94] 0.14[0.70]
SS 0.91[1.00] 0.83[1.00] 0.52[1.00] 0.89[1.00] 0.80[1.00] 0.41[1.00] 0.91[1.00] 0.83[1.00] 0.49[1.00]
40 Perm 0.59[1.00] 0.53[1.00] 0.24[1.00] 0.58[1.00] 0.51[1.00] 0.20[1.00] 0.60[1.00] 0.52[1.00] 0.26[1.00]
AE 0.68[1.00] 0.61[1.00] 0.41[1.00] 0.67[1.00] 0.58[1.00] 0.30[1.00] 0.68[1.00] 0.61[1.00] 0.32[1.00]
Asymptotic 0.60[0.97] 0.49[0.97] 0.08[0.91] 0.55[0.98] 0.42[1.00] 0.11[0.76] 0.60[0.96] 0.47[0.97] 0.11[0.79]
Wald 0.65[0.98] 0.58[0.99] 0.12[0.91] 0.60[1.00] 0.52[1.00] 0.13[0.76] 0.65[0.97] 0.56[0.98] 0.14[0.79]
SS 0.66[1.00] 0.60[1.00] 0.29[1.00] 0.63[1.00] 0.57[1.00] 0.26[1.00] 0.66[1.00] 0.61[1.00] 0.31[1.00]
60 Perm 0.51[0.99] 0.43[1.00] 0.19[1.00] 0.50[1.00] 0.42[1.00] 0.15[1.00] 0.52[1.00] 0.44[1.00] 0.19[1.00]
AE 0.57[1.00] 0.49[1.00] 0.24[1.00] 0.57[1.00] 0.50[1.00] 0.23[1.00] 0.57[1.00] 0.52[1.00] 0.24[1.00]
Asymptotic 0.50[0.98] 0.37[0.98] 0.10[0.78] 0.45[0.98] 0.35[0.98] 0.10[1.00] 0.50[0.99] 0.41[0.98] 0.09[0.64]
Wald 0.53[0.98] 0.45[1.00] 0.13[1.00] 0.49[1.00] 0.43[0.99] 0.13[1.00] 0.53[0.99] 0.48[0.99] 0.12[0.95]
SS 0.54[0.99] 0.50[1.00] 0.23[1.00] 0.52[1.00] 0.46[1.00] 0.20[1.00] 0.54[1.00] 0.49[1.00] 0.23[1.00]
100 Perm 0.42[1.00] 0.35[1.00] 0.14[1.00] 0.40[1.00] 0.33[1.00] 0.11[1.00] 0.42[1.00] 0.36[1.00] 0.14[0.99]
AE 0.47[1.00] 0.41[1.00] 0.18[1.00] 0.45[1.00] 0.39[1.00] 0.17[1.00] 0.46[1.00] 0.42[1.00] 0.18[1.00]
Asymptotic 0.38[0.98] 0.31[0.98] 0.08[0.72] 0.35[0.99] 0.27[0.98] 0.09[0.88] 0.39[0.99] 0.31[0.98] 0.09[0.65]
Wald 0.41[0.99] 0.37[0.99] 0.11[0.96] 0.38[1.00] 0.33[1.00] 0.11[1.00] 0.42[0.99] 0.37[1.00] 0.11[0.82]
SS 0.42[0.99] 0.38[1.00] 0.17[1.00] 0.40[1.00] 0.35[1.00] 0.15[1.00] 0.42[0.99] 0.38[1.00] 0.17[1.00]
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Table 2.4: Simulation results for scenario (ii). Table entries give the empirical width [cov-
erage] of 95% confidence sets or intervals, where γ is the degree of additivity, % treatment
is the percent of n total individuals assigned to treatment in each experiment, Perm is the
permutation confidence set, AE is the attributable effects confidence set, Asymptotic is the
asymptotic confidence interval in Robins (1988), Wald is the usual large sample interval for a
risk difference, and SS is the Santner-Snell Santner and Snell (1980) exact confidence interval.
30% treatment 50% treatment 70% treatment
n Method γ = 0.2 γ = 0.8 γ = 1 γ = 0.2 γ = 0.8 γ = 1 γ = 0.2 γ = 0.8 γ = 1
20 Perm 0.73[1.00] 0.74[0.99] 0.72[0.99] 0.76[1.00] 0.76[0.99] 0.66[0.98] 0.73[1.00] 0.73[0.99] 0.67[0.98]
AE 0.88[1.00] 0.86[1.00] 0.84[1.00] 0.91[1.00] 0.91[1.00] 0.77[0.99] 0.88[1.00] 0.83[1.00] 0.80[0.99]
Asymptotic 0.86[0.99] 0.83[0.95] 0.81[0.89] 0.82[1.00] 0.80[0.92] 0.69[0.93] 0.86[0.99] 0.80[0.93] 0.73[0.92]
Wald 0.91[0.99] 0.89[0.95] 0.86[0.95] 0.85[1.00] 0.85[0.96] 0.75[0.94] 0.91[0.99] 0.86[0.93] 0.78[0.93]
SS 0.94[1.00] 0.93[0.97] 0.93[0.96] 0.91[1.00] 0.90[0.98] 0.78[0.99] 0.94[1.00] 0.93[0.99] 0.78[0.98]
40 Perm 0.60[1.00] 0.60[0.98] 0.59[0.98] 0.59[1.00] 0.59[0.99] 0.54[0.97] 0.60[1.00] 0.60[0.99] 0.56[0.98]
AE 0.69[1.00] 0.69[0.99] 0.67[0.99] 0.68[1.00] 0.67[1.00] 0.64[0.99] 0.68[1.00] 0.69[0.99] 0.64[1.00]
Asymptotic 0.64[0.99] 0.62[0.92] 0.61[0.90] 0.59[1.00] 0.57[0.94] 0.55[0.92] 0.63[0.99] 0.62[0.91] 0.57[0.92]
Wald 0.66[1.00] 0.66[0.95] 0.65[0.93] 0.61[1.00] 0.60[0.94] 0.58[0.95] 0.65[0.99] 0.66[0.95] 0.60[0.94]
SS 0.67[1.00] 0.67[0.97] 0.65[0.96] 0.65[1.00] 0.64[0.98] 0.58[0.97] 0.67[1.00] 0.67[0.98] 0.60[0.97]
60 Perm 0.52[1.00] 0.52[0.99] 0.52[0.98] 0.51[1.00] 0.50[0.98] 0.47[0.98] 0.52[1.00] 0.52[0.99] 0.49[0.97]
AE 0.59[1.00] 0.58[1.00] 0.58[0.99] 0.58[1.00] 0.56[1.00] 0.53[0.99] 0.59[1.00] 0.59[0.99] 0.56[0.98]
Asymptotic 0.53[1.00] 0.52[0.94] 0.51[0.90] 0.49[1.00] 0.47[0.94] 0.47[0.90] 0.53[1.00] 0.52[0.93] 0.49[0.90]
Wald 0.54[1.00] 0.54[0.96] 0.53[0.94] 0.50[1.00] 0.49[0.96] 0.49[0.95] 0.54[1.00] 0.54[0.95] 0.51[0.93]
SS 0.55[1.00] 0.55[0.97] 0.54[0.97] 0.53[1.00] 0.52[0.99] 0.49[0.96] 0.55[1.00] 0.55[0.96] 0.51[0.96]
100 Perm 0.43[1.00] 0.43[0.99] 0.42[0.97] 0.41[1.00] 0.41[0.99] 0.39[0.97] 0.43[1.00] 0.43[0.98] 0.41[0.97]
AE 0.47[1.00] 0.47[1.00] 0.47[0.98] 0.45[1.00] 0.45[0.99] 0.43[0.98] 0.47[1.00] 0.47[0.99] 0.44[0.98]
Asymptotic 0.41[1.00] 0.41[0.96] 0.41[0.92] 0.38[1.00] 0.38[0.96] 0.37[0.94] 0.42[1.00] 0.41[0.94] 0.39[0.94]
Wald 0.42[1.00] 0.42[0.97] 0.42[0.94] 0.39[1.00] 0.39[0.97] 0.38[0.95] 0.42[1.00] 0.42[0.96] 0.40[0.94]
SS 0.43[1.00] 0.43[0.98] 0.42[0.95] 0.41[1.00] 0.41[0.98] 0.39[0.96] 0.43[1.00] 0.43[0.97] 0.41[0.96]
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Table 2.5: Simulation results for scenario (iii). Table entries give the empirical width [cover-
age] of 95% confidence sets or intervals, where ∆ is the true difference in binomial proportions,
% treatment is the percent of n total individuals assigned to treatment in each experiment,
Perm is the permutation confidence set, AE is the attributable effects confidence set, Asymp-
totic is the asymptotic confidence interval in Robins (1988), Wald is the usual large sample
interval for a difference in binomial proportions, and SS is the Santner-Snell Santner and Snell
(1980) exact confidence interval.
30% treatment 50% treatment 70% treatment
n Method ∆ = 0.2 ∆ = 0.5 ∆ = 0.95 ∆ = 0.2 ∆ = 0.5 ∆ = 0.95 ∆ = 0.2 ∆ = 0.5 ∆ = 0.95
20 Perm 0.73[0.95] 0.68[0.95] 0.42[0.90] 0.74[0.96] 0.69[0.94] 0.34[0.92] 0.73[0.95] 0.67[0.94] 0.42[0.91]
AE 0.83[0.98] 0.75[0.98] 0.53[0.90] 0.85[0.98] 0.75[0.98] 0.53[0.92] 0.83[0.99] 0.75[0.98] 0.53[0.91]
Asymptotic 0.78[0.84] 0.63[0.82] 0.11[0.39] 0.73[0.86] 0.59[0.89] 0.11[0.41] 0.78[0.85] 0.61[0.78] 0.11[0.38]
Wald 0.86[0.90] 0.75[0.89] 0.13[0.40] 0.81[0.92] 0.71[0.90] 0.14[0.42] 0.86[0.91] 0.73[0.85] 0.13[0.39]
SS 0.90[0.96] 0.82[0.98] 0.50[1.00] 0.87[0.97] 0.79[0.97] 0.41[0.99] 0.91[0.96] 0.81[0.98] 0.50[1.00]
40 Perm 0.59[0.95] 0.52[0.94] 0.26[0.91] 0.58[0.97] 0.51[0.96] 0.20[0.92] 0.59[0.95] 0.52[0.95] 0.26[0.94]
AE 0.67[0.98] 0.60[0.98] 0.32[0.91] 0.66[0.98] 0.58[0.98] 0.30[0.92] 0.67[0.98] 0.60[0.98] 0.32[0.94]
Asymptotic 0.59[0.90] 0.47[0.86] 0.10[0.61] 0.54[0.88] 0.43[0.88] 0.10[0.61] 0.58[0.88] 0.47[0.87] 0.10[0.66]
Wald 0.64[0.92] 0.56[0.90] 0.12[0.62] 0.59[0.95] 0.52[0.94] 0.12[0.62] 0.63[0.90] 0.56[0.91] 0.13[0.66]
SS 0.66[0.99] 0.60[0.96] 0.31[0.99] 0.63[0.97] 0.56[0.98] 0.25[0.98] 0.65[0.95] 0.59[0.97] 0.31[0.99]
60 Perm 0.51[0.94] 0.44[0.94] 0.20[0.92] 0.49[0.96] 0.42[0.96] 0.15[0.93] 0.51[0.96] 0.44[0.95] 0.20[0.93]
AE 0.57[0.96] 0.51[0.97] 0.24[0.92] 0.56[0.98] 0.50[0.99] 0.23[0.93] 0.57[0.97] 0.50[0.98] 0.24[0.93]
Asymptotic 0.49[0.91] 0.40[0.87] 0.10[0.55] 0.44[0.89] 0.35[0.90] 0.09[0.74] 0.49[0.91] 0.39[0.89] 0.09[0.54]
Wald 0.53[0.93] 0.47[0.92] 0.12[0.80] 0.49[0.93] 0.43[0.95] 0.11[0.76] 0.53[0.92] 0.46[0.93] 0.12[0.78]
SS 0.54[0.94] 0.49[0.96] 0.24[0.99] 0.51[0.97] 0.46[0.97] 0.19[0.81] 0.54[0.95] 0.49[0.96] 0.23[0.99]
100 Perm 0.42[0.95] 0.35[0.94] 0.14[0.93] 0.39[0.96] 0.33[0.93] 0.11[0.95] 0.42[0.96] 0.35[0.93] 0.14[0.93]
AE 0.46[0.97] 0.41[0.98] 0.18[0.96] 0.45[0.98] 0.39[0.98] 0.17[0.96] 0.46[0.98] 0.41[0.97] 0.18[0.96]
Asymptotic 0.38[0.90] 0.31[0.88] 0.08[0.64] 0.35[0.90] 0.27[0.88] 0.08[0.68] 0.38[0.92] 0.31[0.87] 0.08[0.64]
Wald 0.41[0.92] 0.36[0.93] 0.11[0.79] 0.38[0.94] 0.34[0.94] 0.10[0.91] 0.41[0.94] 0.36[0.93] 0.11[0.79]
SS 0.42[0.95] 0.38[0.96] 0.17[0.98] 0.40[0.95] 0.35[0.95] 0.14[0.98] 0.42[0.96] 0.38[0.96] 0.17[0.99]
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Figure 2.1: Coverage probability (top) and average width (bottom) of the attributable effects
and permutation test based confidence sets and the asymptotic confidence interval for the
average treatment effect τ .
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CHAPTER 3: EXACT CONFIDENCE INTERVALS IN THE PRESENCE
OF INTERFERENCE
3.1 Introduction
In a randomized experiment, it is commonly assumed that an individual only has two
potential outcomes: an outcome on control, and an outcome on treatment. That an individual
has only two potential outcomes assumes no interference (Cox, 1958) between individuals, i.e.,
an individual’s potential outcomes are unaffected by the treatment assignment of any other
individual in the study. There are many settings where this assumption of no interference is
clearly violated (Hong and Raudenbush, 2006; Sobel, 2006; Rosenbaum, 2007).
Partial interference holds when individuals can be partitioned into groups such that there
is no interference between individuals in different groups. In settings where partial interference
holds, two-stage randomized experiments have been suggested as a study design for drawing
inference about treatment (i.e., causal) effects. Two-stage randomized experiments proceed by
(i) randomizing groups to treatment strategies and (ii) randomizing individuals within groups
to different treatments based on the treatment strategy assigned to their group in stage (i).
Two-stage randomized experiments are found in many fields of study, e.g., infectious diseases
(Baird et al., 2012), medicine (Borm et al., 2005), economics (Duflo and Saez, 2003), and
political science (Ichino and Schu¨ndeln, 2012; Sinclair et al., 2012). Building upon ideas in
Halloran et al. (1991), Hudgens and Halloran (2008) defined and derived unbiased estimators
for the direct, indirect, total, and overall effects of treatment in a two-stage randomized
experiment assuming partial interference. Liu and Hudgens (2014) showed that Wald-type
confidence intervals based on these estimators perform well when the number of groups is large;
however, often the number of groups may not be large enough. For example, Moulton et al.
(2001) describe a group-randomized vaccine trial involving approximately 9,000 individuals
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but only 38 groups. Tchetgen Tchetgen and VanderWeele (2012), henceforth TV, proposed
exact confidence intervals using the Hoeffding inequality for these four effects in a two-stage
randomized experiment with partial interference. Unfortunately, as will be shown below, the
TV intervals can be very wide and conservative.
In this paper, we propose different exact confidence intervals based on inverting exact
hypothesis tests that tend to be less conservative than TV. The remainder of the paper is
organized as follows. In §2, treatment effects in the presence of interference are defined and
existing inferential results are reviewed. In §3, the assumption of stratified interference is
presented and bounds are derived for the causal effects under this assumption. In §4 the
proposed new exact confidence intervals are described by inverting certain permutation tests.
§5 concludes with a simulation study comparing the TV, asymptotic, and new exact confidence
intervals.
3.2 Preliminaries
3.2.1 Estimands
Consider a finite population of N individuals partitioned into k groups with ni individuals
in group i for i = 1, . . . , k. Assume partial interference, i.e., there is no interference between
individuals in different groups. Consider a two-stage randomized experiment wherein h of
k groups are assigned to strategy α1 and k − h are assigned to α0 in the first stage, where
strategy αs specifies that m
s
i of ni individuals will receive treatment. For example, strategy
α0 might entail assigning (approximately) 1/3 of individuals within a group to treatment
whereas strategy α1 might entail assigning (approximately) 2/3 of individuals within a group
to treatment (see TV for further discussion about different types of treatment allocation
strategies). Let Si = 1 if group i is randomized to α1 and 0 otherwise so that Pr[Si = 1] =
h/k. In the second stage, individuals will be randomized to treatment conditional on group
assignment in the first stage. Let Zij = 1 if individual j in group i is assigned treatment
and 0 otherwise. Let Zi = (Zi1, . . . , Zini) be the random vector of treatment assignments
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for group i taking on values zi ∈ R(ni,msi ), the set of all vectors of length ni composed of
msi elements equal to 1 and ni −msi elements equal to 0. Additionally, let Zi(j) denote the
random vector of treatment assignments in group i excluding individual j taking on values
zi(j) ∈ R(ni − 1,msi − zij).
Let yij(zi) be the binary potential outcome for individual j in group i when group i re-
ceives treatment vector zi. A randomization inference framework is adopted wherein potential
outcomes are fixed features of the finite population of N individuals and only treatment as-
signments S and Z are random (as in Sobel (2006); Rosenbaum (2007); Hudgens and Halloran
(2008)). Define the average potential outcome for individual j in group i on treatment z = 0, 1
under strategy αs as
y¯ij(z;αs) ≡
∑
ω∈R(ni−1,msi−z)
yij(zij = z, zi(j) = ω) Pr(Zi(j) = ω|Zij = z;Si = s) (3.1)
where Pr(Zi(j) = ω|Zij = z;Si = s) =
(
ni−1
msi−z
)−1
. Henceforth, let
∑
i =
∑k
i=1 and
∑
j =∑ni
j=1. For treatment z under strategy αs define the group average potential outcome as
y¯i(z;αs) ≡ n−1i
∑
j y¯ij(z;αs), and the population average potential outcome as y¯(z;αs) ≡
k−1
∑
i y¯i(z;αs). Define the average potential outcome for individual j in group i under
strategy αs as
y¯ij(αs) ≡
∑
ω∈R(ni,msi )
yij(zi = ω) Pr(Zi = ω;Si = s), (3.2)
the group average potential outcome as y¯i(αs) ≡ n−1i
∑
j y¯ij(αs), and the population average
potential outcome as y¯(αs) ≡ k−1i
∑
i y¯i(αs). Define the direct effect of treatment for strategy
αs as DE(αs) = y¯(0;αs) − y¯(1;αs), the indirect effect of α0 versus α1 as IE(α0, α1) =
y¯(0;α0)− y¯(0;α1), the total effect as TE(α0, α1) = y¯(0;α0)− y¯(1;α1), and the overall effect
of α0 versus α1 as OE(α0, α1) = y¯(α0)− y¯(α1); see Hudgens and Halloran (2008) and TV for
additional discussion regarding these effects.
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3.2.2 Existing Inferential Results
Hudgens and Halloran (2008) derived unbiased estimators for all population average po-
tential outcomes, and thus for the four causal effects. Noting that Pr[Si = s] and Pr[Zij =
z|Si = s] are known by design, the estimator
yˆ(z;αs) = k
−1∑
i
1{Si = s}yˆi(z;αs)
Pr[Si = s]
(3.3)
where yˆi(z;αs) = n
−1
i
∑
j 1{Zij = z}yij(Zij)/Pr[Zij = z|Si = s] is unbiased for y¯(z;αs).
Additionally, the estimator
yˆ(αs) = k
−1∑
i
1(Si = s)n
−1
i
∑
j yij(Zij)
Pr[Si = s]
(3.4)
is unbiased for y¯(αs). Unbiased estimators for the effects of interest follow immediately:
D̂E(αs) = yˆ(0;αs) − yˆ(1;αs), ÎE(α0, α1) = yˆ(0;α0) − yˆ(0;α1), T̂E(α0, α1) = yˆ(0;α0) −
yˆ(1;α1), and ÔE(α0, α1) = yˆ(α0)− yˆ(α1).
TV proposed exact confidence intervals based on the Hoeffding inequality for the effects
of interest in a two-stage randomized experiment where partial interference is assumed. In
particular, for any γ ∈ {0, 1}, D̂E(αs) ± ∗D(γ, αs, qs, k) is a 1 − γ exact confidence interval
for DE(αs) where 
∗
D(γ, αs, qs, k) is given in equation (17) of TV for s = 0, 1. Addition-
ally, ÎE(α0, α1)± ∗(γ, α0, q0, α1, q1, k), T̂E(α0, α1)± ∗(γ, α0, q0, α1, q1, k), and ÔE(α0, α1)±
∗(γ, α0, q0, α1, q1, k) are all 1−γ exact confidence intervals for their target parameters where
∗(γ, α0, q0, α1, q1, k) is given in Theorem 3 of TV.
Liu and Hudgens (2014) examined conditions under which Wald-type intervals D̂E(αs)±
z(1−γ/2){v̂ar(D̂E(αs))}1/2 and Chebyshev-type intervals D̂E(αs) ± {v̂ar(D̂E(αs))/γ}1/2 are
valid, large sample confidence intervals for DE(αs), where z(1−γ/2) is the 1− γ/2 quantile for
the standard normal distribution and v̂ar(D̂E(αs)) is an estimator of the variance of D̂E(αs)
for s = 0, 1. They also considered Wald and Chebyshev-type confidence intervals for the
indirect, total, and overall effects.
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3.3 Bounds Under Stratified Interference
Exact randomization based inference about the four effects is challenging without further
assumptions as the experiment reveals only N of the
∑
i
∑
j
{( ni
m0i
)
+
( ni
m1i
)}
total potential
outcomes. One such additional assumption is stratified interference (Hudgens and Halloran,
2008), which assumes that individual j in group i has the same potential outcome when
assigned control or treatment as long as a fixed number of other individuals in group i are
assigned treatment, i.e.,
yij(zi) = yij(z
′
i) for all zi, z
′
i ∈ R(ni,msi ) such that zij = z′ij . (3.5)
Under (3.5), individual j in group i only has four potential outcomes, which we denote
by yij(z;αs) for z, s = 0, 1, so that the experiment reveals the observed outcome Yij =∑
z,s=0,1 1{Zij = z;Si = s}yij(z;αs) for each individual and thus N of the 4N total poten-
tial outcomes. Furthermore, (3.5) implies that y¯ij(z;αs) = yij(z;αs), and that y¯ij(αs) =
wsi yij(1;αs) + (1− wsi )yij(0;αs) ≡ yij(αs) where wsi = Pr[Zij = 1|Si = s] = msi/ni.
Under (3.5), the observed data form bounded sets for all effects contained in the interval
[−1, 1]. The bounded sets have widths less than two where here and in the sequel the width
of a set is defined to be the difference between its maximum and minimum values. Consider
DE(α0) = k
−1∑
i n
−1
i
∑
j{yij(0;α0)− yij(1;α0)} for illustration. For the
∑
i
∑
j(1−Si)(1−
Zij) individuals with Si = Zij = 0, yij(0;α0) is revealed; however, for the N −
∑
i
∑
j(1 −
Si)(1 − Zij) individuals with Si = 1 or Zij = 1, yij(0;α0) is missing and only known to
be 0 or 1. Let ~y(z;αs) be the N -dimensional vector of potential outcomes for treatment z
under strategy αs. Under (3.5), a lower bound for DE(α0) is found by filling in all missing
potential outcomes in ~y(0;α0) as 0 and all missing potential outcomes in ~y(1;α0) as 1. An
upper bound for DE(α0) is found by filling in all missing potential outcomes in ~y(0;α0) as 1
and all missing potential outcomes in ~y(1;α0) as 0. Simple algebra shows that width of the
bounded set for DE(α0) is equal to 2− (k− h)/k. The width of this bounded set approaches
1 as (k − h)/k → 1, i.e., as more groups are randomized to α0.
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Similar logic leads to bounds for the other effects. The width of the bounded set for
DE(α1) is equal to 2 − h/k which approaches 1 as h/k → 1. The width of the bounded set
for IE(α0, α1) is equal to 2− k−1
∑
i n
−1
i
∑
j(1− Zij) which approaches 1 as the proportion
of individuals assigned Zij = 0 approaches 1. The width of the bounded set for TE(α0, α1) is
equal to 2−k−1∑i n−1i {(1−Si)∑j(1−Zij)+Si∑j Zij} which approaches 1 as the proportion
of individuals with Si = Zij = 0 or Si = Zij = 1 approaches 1. Lower and upper bounds
for OE(α0, α1) can be derived similarly but the corresponding width does not have a simple
closed form.
3.4 EIT Confidence Intervals
In addition to leading to unbiased estimators and bounds, the observed data can be used
to form 1− γ confidence sets for the four effects. The confidence sets are formed by inverting
hypothesis tests about the potential outcomes that define the effect of interest. This section is
divided into two parts: §3.4.1 outlines how the confidence sets are formed and §3.4.2 presents
a computationally feasible algorithm for constructing an interval that contains the exact
confidence set. Henceforth this interval is referred to as the exact inverted test (EIT).
3.4.1 An Exact Confidence Set
The methods to follow can be generalized to any effect, so consider DE(α0). Inference
about DE(α0) concerns the vectors ~y(0;α0) and ~y(1;α0), which are partially revealed by
the experiment. A hypothesis about these vectors is considered sharp if it completely fills
in the potential outcomes not revealed by the experiment. A sharp null H0 : ~y(0;α0) =
~y0(0;α0), ~y(1;α0) = ~y
0(1;α0) maps to a value of DE(α0), which we denote DE
0(α0). Only
sharp null hypotheses that are compatible with the observed data need to be tested as other
sharp nulls can be rejected with zero probability of making a type I error. Thus for each
sharp null to be tested, the implied null value DE0(α0) will be a member of the bounded
set derived in §3. There are B1 = 2
∑
i(1−Si)ni4
∑
i Sini sharp null hypotheses to test, as
individuals with Si = 0 have only one missing potential outcome with two possible values
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{0, 1}, and individuals with Si = 1 have two missing potential outcomes with four possible
values {0, 1} × {0, 1}.
After filling in the missing potential outcomes under H0, the null distribution of the test
statistic D̂E(α0) can be found by computing the statistic, denoted by D̂Ec(α0), for each of
the c = 1, . . . , C1 possible experiments under H0, where C1 =
∑
S∈S
∏k
i=1
( ni
m1i
)Si( ni
m0i
)(1−Si)
and S is the set of all possible values of the vector S such that |S| = (kh). A two-sided p-
value to test H0 is given by p0 =
∑C1
c=1 1{|D̂Ec(α0)−DE0(α0)| ≥ |D̂E(α0)−DE0(α0)|}/C1.
If p0 < γ, H0 is rejected. Note p0 is a function of the null hypothesis vectors ~y
0(0;α0)
and ~y0(1;α0). Let p(DE
0(α0)) denote the set of all p0 which are functions of compatible
vectors ~y0(0;α0) and ~y
0(1;α0) that map to DE
0(α0). A 1 − γ confidence set for DE(α0) is
{DE0(α0) : max{p(DE0(α0))} ≥ γ}. P-values, and thus confidence sets, can be found in an
analogous manner for the other effects.
3.4.2 A Computationally Feasible Algorithm
Finding the exact confidence set for DE(α0) described above entails testing B1 hypotheses,
where each hypothesis test involves C1 randomizations. As N becomes large, the computa-
tional time necessary to perform B1 × C1 operations grows exponentially. For illustration
of the problem, consider two examples in which h = 1 of k = 1 groups are assigned α0, in
which m01 = 10 of n1 = 20 individuals are randomized to treatment such that B1 = 2
20 and
C1 =
(
20
10
)
= 184, 756. Suppose there are two cases of observed data: (a) 5 of 10 unexposed
experienced an event, and 5 of 10 exposed experienced an event, and (b) 8 of 10 unexposed
experienced an event and 2 of 10 exposed experienced an event. Figure 4.1 displays a plot of
DE0(α0) versus p(DE
0(α0)) for both examples. The bounded set and 95% exact confidence
set for DE0(α0), respectively are {−0.5,−0.45, . . . , 0.45, 0.5} and {−0.35,−0.3, . . . , 0.3, 0.35}
in (a) and {−0.2,−0.15, . . . , 0.75, 0.8} and {0.15, 0.2, . . . , 0.75, 0.8} in (b).
To save computational time in finding the confidence sets, B2 < B1 of the sharp null
hypotheses can be tested, and a random sample of C2 < C1 randomizations can be used
to compute the p-value for each sharp null. The lack of symmetry in Figure 1 (b) suggests
48
targeting the lower and upper limit of the confidence set separately. Consider the following
targeting algorithm for the lower bound of a confidence set for DE(α0) where D̂E(α0)l denotes
the lower bound for DE(α0), and yˆ(z;α0)l and yˆ(z;α0)u denote the lower and upper bounds,
respectively, for y¯(z;α0). An analogous algorithm can be used to target the upper limit of
the confidence set for DE(α0).
1. Test the unique sharp null about ~y(0;α0) and ~y(1;α0) that maps to D̂E(α0)l. If the
corresponding p-value p0 ≥ γ, let D̂E(α0)l be the lower limit of the confidence set and
do not proceed. Otherwise, let l = D̂E(α0) and let pl = 1− 1/B2. Let L = {D̂E(α0)l}
and P = {p0}.
2. Fill in the missingness in ~y(0;α0) with samples from a Bernoulli distribution with mean
f({yˆ(0;α0)l + yˆ(1;α0)u + qpl(D̂E(α0)l, l)}/2) and fill in the missingness in ~y(1;α0) with
samples from a Bernoulli distribution with mean f({yˆ(0;α0)l+yˆ(1;α0)u−qpl(D̂E(α0)l, l)}/2)
where qp(a, b) = (1−p)a+pb, and f(x) = x if 0 ≤ x ≤ 1, f(x) = 0 if x < 0, and f(x) = 1
if x > 1.
3. If the sampled sharp null maps to a value DE0(α0) ∈ [D̂E(α0)l, l], add DE0(α0) to the
set L, add the corresponding p0 to P, and if p0 ≥ γ then update l to equal DE0(α0).
Otherwise, do not compute a p-value corresponding to the sampled sharp null and let
pl = pl − 1/B2.
4. Repeat Steps 2 and 3 B2/2− 1 times.
The algorithm is modified slightly for OE(α0, α1) as it involves all four vectors ~y(z;αs),
z, s = 0, 1. Let yˆ(αs)l and yˆ(αs)u be the lower and upper limits, respectively, for y¯(αs)
under (3.5). If p0 < γ for OE(α0, α1)l, set l = ÔE(α0, α1) and fill in the missingness
in ~y(0;α0) and ~y(1;α0) with samples from a Bernoulli distribution with mean f({yˆ(α0)l +
yˆ(α1)u+qpl(ÔE(α0, α1)l, l)}/2) where pl = 1−1/B2. A p-value is computed if OE0(α0, α1) ∈
[ÔE(α0, α1)l, l] and if not pl = pl − 1/B2. If p0 ≥ γ for OE(α0, α1)l, l is set to equal
OE0(α0, α1). The upper endpoint can be approximated using an analogous approach.
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Let t be the function from P to L that maps each p-value p0 in P to the null value
of DE0(α0) in L which corresponds to the sharp null hypothesis which generated p0. Let
R = {max{p ∈ P : t(p) = l} : l ∈ L}. Let r1 = min{r ∈ R : r ≥ γ} and let r2 = max{r ∈
R : r < γ}. Let li = t(ri) for i = 1, 2. The lower limit of the confidence set l∗ is found by
local linear interpolation by finding the x-coordinate for the point at which a line drawn from
(l2, r2) to (l1, r1) intersects a horizontal line at γ, i.e., l
∗ = l2 + (γ − r2)(l2 − l1)/(r2 − r1).
The upper limit u∗ is found analogously. As B2 → B1 and C2 → C1, the interval [l∗, u∗] will
contain the exact confidence set described in §3.4.1 with probability approaching 1.
The R package interferenceCI is available on CRAN (Rigdon, 2015) for computing EIT
confidence intervals via this algorithm for the four effects assuming stratified interference
when the outcome is binary. The Wald, Chebyshev, and TV intervals are also computed in
the package.
3.5 Comparisons Via Simulation
A simulation study was carried out to compare the asymptotic, TV, and EIT confidence
intervals. The simulation proceeded as follows for fixed values of α0, α1, DE(α0), DE(α1),
IE(α0, α1), k, ni = n for i = 1, . . . , k such that N = kn:
0. Potential outcomes were generated by first fixing the vectors ~y(z;αs) for z, s = 0, 1
to be length N vectors of all 0s. Group membership was assigned by letting elements
n(i−1)+1, . . . , ni of each vector belong to group i = 1, . . . , k. Then, N(0.5+DE(α0)/2)
elements in ~y(0;α0) were randomly set to equal 1 and N(0.5−DE(α0)/2) elements in
~y(1;α0) were randomly set to equal 1. Then, N(0.5+DE(α0)/2−IE(α0, α1)) elements in
~y(0;α1) were randomly set to equal 1. Finally, N(0.5+DE(α0)/2−IE(α0, α1)−DE(α1))
elements in ~y(1;α1) were randomly set to equal 1.
1. Observed data were generated by (i) randomly assigning h of k groups to strategy α1
and (ii) randomly assigning msi = αsn of n individuals per group to treatment for
s = 0, 1. Observed outcomes followed based on these treatment assignments and the
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potential outcomes from step 0.
2. For each effect, 95% confidence intervals were computed using the observed data gen-
erated in step 1.
3. Steps 1-2 were repeated 1000 times.
In the simulation we let k = n = 10 or k = n = 20 with h = k/2, m0i = 0.3n under
α0, m
1
i = 0.6n under α1, DE(α0) = 0.95, DE(α1) = 0.3, and IE(α0, α1) = 0.5 (such that
TE(α0, α1) = 0.8 and OE(α0, α1) = 0.395). In the targeted sampling algorithm, B2 = C2 =
100 such that B2/B1 and C2/C1 were less than 10
−20 for all effects. Table 3.1 displays
average widths and coverages for Wald, EIT, Chebyshev, and TV. Wald and Chebyshev fail
to achieve nominal coverage for DE(α0) when k = n = 10 and Wald additionally fails to
cover for DE(α0) when k = n = 20 and for IE(α0, α1) and TE(α0, α1) when k = n = 10. As
guaranteed by their respective constructions, EIT and TV achieve nominal coverage for all
setups; however, EIT has narrower width than TV in all setups. In fact, EIT is an order of
magnitude narrower than TV in three instances: DE(α0), TE(α0, α1), and OE(α0, α1) when
k = n = 20.
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3.6 Tables and Figures
Table 3.1: Empirical width and coverage [in brackets] of Wald (W), EIT, Chebyshev (C), and
TV 95% CIs for simulation study discussed in Section 3.5.
n k DE(0.3) DE(0.6) IE(0.3, 0.6) TE(0.3, 0.6) OE(0.3, 0.6)
W 10 10 0.13 [0.84] 0.51 [0.96] 0.39 [0.93] 0.30 [0.93] 0.24 [0.94]
20 20 0.09 [0.89] 0.26 [0.96] 0.21 [0.95] 0.14 [0.98] 0.11 [0.97]
EIT 10 10 0.28 [0.98] 0.52 [0.98] 0.47 [0.99] 0.31 [0.98] 0.36 [1.00]
20 20 0.12 [0.98] 0.27 [0.98] 0.24 [0.98] 0.14 [0.98] 0.18 [1.00]
C 10 10 0.22 [0.84] 1.15 [1.00] 0.84 [1.00] 0.54 [1.00] 0.54 [1.00]
20 20 0.15 [0.99] 0.59 [1.00] 0.49 [1.00] 0.32 [1.00] 0.26 [1.00]
TV 10 10 1.95 [1.00] 2.00 [1.00] 2.00 [1.00] 2.00 [1.00] 2.00 [1.00]
20 20 1.41 [1.00] 2.00 [1.00] 1.86 [1.00] 1.56 [1.00] 1.96 [1.00]
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Figure 3.1: Plot of DE(α0) versus p(DE(α0)) for examples (a) and (b) as outlined in Sec-
tion 3.4.2.
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CHAPTER 4: BAYESIAN CAUSAL INFERENCE WITH INTERFERENCE
4.1 Introduction
Recently, much research has focused on statistical inference in the presence of interference
(Hudgens and Halloran, 2008; Tchetgen Tchetgen and VanderWeele, 2012; Aronow, 2012;
Bowers et al., 2013). Interference is present when the outcome of one individual is affected
by the treatment of any other individual in a randomized experiment or observational study.
More generally, interference may occur in any group of humans that communicate or compete
with one another. Interference is a violation of the stable unit treatment value assumption
(SUTVA) Rubin (1980), a fundamental assumption invoked in many causal evaluations of
treatments.
In a two-stage randomized experiment where interference is present, inferential targets
have been defined and estimated unbiasedly (Hudgens and Halloran, 2008), and large sample
(Liu and Hudgens, 2014) and exact (Tchetgen Tchetgen and VanderWeele, 2012) confidence
intervals have been proposed. Statistical methods that do not require adjustments for con-
founding are appropriate for two-stage randomized experiments, but these experiments are
rare. More common are observational studies with clustered data with possible interference
in which individuals self-select treatment.
It is possible and even likely in observational studies that the relationship between ex-
posure and outcome is confounded by some other variable. Many strategies have emerged
in the causal literature to adjust for such possibilities, two of which are the focus of this
paper: inverse probability weighting (IPW) and outcome modeling. As the two dominant
schools of statistical thought are frequentist and Bayesian, approaches to evaluating causal
exposure-outcome relationships in observational studies with interference may be (1) IPW
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frequentist as in Tchetgen Tchetgen and VanderWeele (2012), (2) IPW Bayesian, (3) out-
come frequentist, and (4) outcome Bayesian. IPW Bayesian approaches are impossible due
to difficulties in constructing a likelihood. An (2010) proposes Bayesian methods using the
propensity score for matching and regression. To our knowledge, the literature on Bayesian
methods for causal inference in the presence of interference is limited. Toulis and Kao (2013)
estimate causal peer influence effects using a frequentist and a Bayesian procedure. Crowley
et al. (2014) perform a Bayesian causal analysis on the effects of Haloperidol in paired mice
where SUTVA is an untenable assumption.
In this paper, we compare and contrast IPW frequentist, outcome frequentist, and outcome
Bayesian approaches to causal inference in an observational study with interference. In Section
2, the motivating example for this research is presented. In Section 3, simulations motivated
by the example in Section 2 are conducted without interference. In Section 4, simulations are
conducted that allow for interference. In Section 5 the Bayesian methods for observational
data with interference are applied to the motivating example. Section 6 concludes with a
discussion.
4.2 Motivating Example
Researchers studying the preventive effects of bed nets on malaria outcome have observed
findings that may suggest interference within communities. In the Wosera area of Papua
New Guinea, Hii et al. (2001) found that untreated bed nets have a substantial impact on
malaria prevalence in high coverage areas that is greater than can be accounted for by personal
protection. In the Nyanza Province in western Kenya, Hawley et al. (2003) found a similar
strong community effect of treated bed nets, hypothesizing that these effects were due to
reduced longevity of mosquito populations forced to expend extra energy in search of human
blood.
The 2007 Demographic and Health Survey in the Democratic Republic of the Congo,
henceforth DHS, was a nationally representative survey designed to provide information on
fertility, mortality, sexually transmitted infections, mosquito net use, and malaria outcome,
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among other health issues. In total, nine thousand households were surveyed. Malaria out-
come was determined by real-time PCR assays on genomic DNA from dried blood spots.
Data exist for 8,844 individuals in 300 communities ranging in size from 4 to 52 individuals
with a mean of 29.48. In the DHS, 20% of individuals self-reported using a bed net the pre-
vious night. The proportion of individuals within each group who reported using a bed net
the previous night had 1st, 2nd, and 3rd quartiles equal to 4%, 14%, and 32%, respectively.
Messina et al. (2011) modeled malaria status in these data as a function of group and indi-
vidual covariates in a multilevel logistic regression. Although individual bed net usage was
significant when entered alone in the model, it was no longer significant when group level bed
net coverage was included in the model.
Table 4.1 suggests that interference may be present in the DHS by displaying malaria
incidence in those with and without bed nets while grouping the 300 communities by septiles
of community bednet usage. Those individuals without bed nets in the first quartile of group
coverage were 4% more likely to contract malaria as those in the fourth quartile of group
coverage. In Section 5, a re-analysis of these data are conducted that allows for interference.
4.3 Observational Study Inference Without Interference
Consider an observational study without interference with binary outcome Y (e.g. malaria),
binary exposure Z (e.g., bed net use), and covariates X. For individual j = 1, . . . , n, let Yj(z)
be the outcome at exposure level z = 0, 1. Let Xj be an observed covariate, and Zj be the
observed exposure. The observed outcome is Yj = ZjYj(1) + (1 − Zj)Yj(0). Assuming that
(Y (0), Y (1), Z,X) are random variables, the target of inference is the population average
causal effect, τ = E[Y (0)] − E[Y (1)]. As the outcome is binary, τ ∈ [−1, 1]. If Y is malaria
outcome and Z is bed net use, values of τ close to 1 indicate significant preventive effects of
bed net use, values close to 0 indicate no effect, and values close to -1 indicate harm caused
by bed net use.
In a randomized trial, inference on τ is straightforward using well known methods. The
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estimator
τˆ =
1
n
n∑
j=1
1{Zj = 0}Yj
Pr[Zj = 0]
− 1
n
n∑
j=1
1{Zj = 1}Yj
Pr[Zj = 1]
(4.1)
is unbiased because Y (0), Y (1) ⊥ Z, i.e., treatment assignment is independent of potential
outcomes. The quantity Pr[Zj = z] ≡ nz/n where nz =
∑n
j=1 1{Zj = z} is known in advance
so that τˆ = pˆ0 − pˆ1 where pz =
∑n
j=1 1{Zj = z}Yj/nz for z = 0, 1, is the familiar difference
in proportions.
In a randomized trial, a commonly used interval estimator for τ is the large sample Wald
confidence interval
τˆ ± z1−α/2
√
pˆ0(1− pˆ0)/n0 + pˆ1(1− pˆ1)/n1 (4.2)
where zc is the c
th quantile of a standard normal distribution. The interval in (4.2) will
contain τ with probability 1− α as n→∞.
4.3.1 Inverse Probability Weighted Estimation
Inference on τ in an observational study is more difficult as it is unlikely that treatment
assignment is independent of potential outcomes and Pr[Zj = z] is not known in advance.
The naive estimator τˆ will be subject to confounding, in which the same characteristics that
lead an individual to be exposed to a treatment may also be associated with the potential
outcome. When all of the confounders X are measured, it may be reasonable to assume
Y (0), Y (1) ⊥ Z|X (4.3)
i.e., strong ignorability (Rosenbaum and Rubin, 1983). Suppose further that the relationship
between Z and X is represented by the propensity score e(X) = Pr[Z = 1|X]. In such a case,
the estimator
τˆ IPW =
1
n
n∑
j=1
1{Zj = 0}Yj
1− ej(X) −
1
n
n∑
j=1
1{Zj = 1}Yj
ej(X)
(4.4)
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is unbiased. In practice, e(X) is rarely known and must be estimated using logistic regression
or some other modeling strategy, e.g.
τˆ IPWe =
1
n
n∑
j=1
1{Zj = 0}Yj
1− eˆj(X) −
1
n
n∑
j=1
1{Zj = 1}Yj
eˆj(X)
(4.5)
When the propensity score is known, τˆ IPW is consistent for τ and asymptotically Normal, and
when the propensity score is estimated τˆ IPWe is consistent for τ and asymptotically Normal
(Lunceford and Davidian, 2004).
4.3.2 Outcome Modeling
An alternative to IPW is outcome modeling. It follows from (4.3) that for z = 0, 1
EX [EY |X(Y |Z = z,X)] = EX [EY |X(Y (z)|Z = z,X)]
= EX [EY |X(Y (z)|X)]
= E[Y (z)] (4.6)
Thus, τ can be directly estimated using outcome (regression) models for E[Y |Z,X]. The
parameters β in the outcome model are estimated using observed data. The model predicted
potential outcomes are used to estimate τ as follows
τˆ o =
1
n
n∑
j=1
[E{Yj(0)|Z,X, βˆ} − E{Yj(1)|Z,X, βˆ}] (4.7)
The large sample distribution and variance of τˆ o can be found using M-estimation theory
(Stefanski and Boos, 2002).
4.3.3 A Bayesian Approach
Inference on τ can be carried out using a Bayesian approach. Let θ be a vector of parame-
ters of interest, and let Y = Y (0), Y (1) be the potential outcomes. Partition Y = (Y obs, Y mis)
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where Y obs is the part of Y sampled by Z in the study, and Y mis are the unobserved po-
tential outcomes. Define X = (Xobs, Xmis) similarly, but for now assume that X is fully
observed so that X = Xobs. Inference on τ is carried out using the posterior distribution
f(τ |Y obs, Xobs, Z). Under (4.3), sampling from the posterior distribution can be accomplished
through specifying the conditional distribution of Y given X, Z, and θ, f(Y |Xobs, Z, θ), and
a prior distribution on θ, f(θ) (Rubin, 1978, Section 4). The following Gibbs sampler can be
used to sample from the posterior distribution:
1. Sample initial values for θ from the prior f(θ).
2. Sample values for Y mis conditional on θ from f(Y mis|Y obs, Xobs, Z, θ). Causal effects
that are functions of Y , τ(Y ), can be computed.
3. Sample values for θ from f(θ|Y obs, Y mis, Xobs, Z), i.e., conditional on the sampled Y mis
in step 2. Causal effects that are functions of θ, τ(θ), can be computed.
4. Iterate until convergence.
If inference concerns the sample average causal effect, then f(τ(Y )|Y obs, Xobs, Z) is the
target of inference. If inferences are being drawn about the population average causal effect
(as in this paper), then f(τ(θ)|Y obs, Xobs, Z) is the target of inference. The posterior mean
and credible interval may serve as point and interval estimates, respectively, of the causal
effect τ . In contrast to the outcome modeling strategy, the Bayesian strategy can deal with
missingness in X in a simple and intuitive manner.
4.3.4 A Simulation Study
The naive, IPW, outcome, and Bayesian point and interval estimators were evaluated
via a simulation study motivated by the DHS. For individual j = 1, . . . , n, let Yj(z) be the
potential malaria outcome at exposure level z = 0, 1, let Xj be the binary covariate proximity
to an urban space, and let Zj be the observed bed net use. The simulation proceeded as
follows:
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The simulation proceeded as follows:
1. For individual j = 1, . . . , n, Xj was randomly sampled from f(X)
2. For each individual Zj was self-selected from a Bernoulli distribution with mean L
−1(γ0+
γ1Xj) in which Xj was observed in step 1
3. For each individual the malaria outcome Yj was sampled from a Bernoulli distribution
with mean L−1(β0 + β1Zj + β2Xj)
4. Point estimates and 95% confidence (or credible) intervals for τ were computed using the
naive, inverse probability weighted, outcome regression, and Bayesian approaches. In
the Bayesian approach, the burn-in was 1100, no thinning was used, and 10000 samples
from the posterior were taken.
5. Steps 1-4 were repeated 1000 times.
Consequently, the true causal effect was equal to
τ =
∫
X
{L−1(β0 + β2X)− L−1(β0 + β1 + β2X)}f(X)dX (4.8)
where here and in the sequel L(x) is shorthand for logit(x) = log{x/(1− x)}.
In the Bayesian approach in the simulation above, non-informative priors were used on
all model parameters, i.e., β0, β1, β2
iid∼ N(0, 4) such that 95% of the prior probability for all
odds ratios was in [0.02, 50.4]. Additionally, the correct outcome model Pr[Yj(z) = 1|Xj ]
was used in the regression and Bayesian approaches and the correct propensity score model
Pr[Zj = 1|Xj ] was used in the IPW estimator.
Table 4.2 displays simulation results in which the true parameters were estimated using
the DHS data such that β0 = −0.49, β1 = −0.39, β2 = −0.63, γ0 = −1.61, γ1 = 0.47, and
where Xj were randomly sampled from a Bernoulli distribution with mean 0.45 implying
that τ = 0.077. The results in Table 4.2 confirm that IPW and Bayes both adjust for
the confounding present in the naive estimator. As pointed out in Lunceford and Davidian
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(2004), the IPW estimator with estimated propensity score has narrower width than the
IPW estimator with known propensity score. The frequentist outcome, IPW, and Bayesian
approaches all have similar widths for n = 50, 200, and 1000; however, only the Bayesian
approach has nominal 95% coverage for n = 50. In the next section, a simulation study is
conducted mirroring the one in this section with the additional feature of interference.
4.4 Observational Study Inference with Interference
In this section, methods for inference with interference in observational studies are re-
viewed and a new approach is proposed. Let Yij(zi) be the binary outcome (e.g., malaria)
for individual j = 1, . . . , ni in group i = 1, . . . , k when group i has exposure zi (e.g., bed
net use). Let zi ∈ Z(ni) where Z(ni) contains the 2ni realizations of Zi, e.g., Z(2) =
{(0, 0), (0, 1), (1, 0), (1, 1)}. The vector of exposures can be partitioned as zi = (zij , zi(j))
where zij is the treatment assignment for individual j and zi(j) is the treatment assignment
for all individuals except individual j. In this formulation, both Yij(zi) and Zi are random
variables. Throughout, partial interference (Sobel, 2006) is assumed such that interference
can only occur within groups. Thus, each individual’s potential outcomes are a set of random
variables {Yij(zi) : zi ∈ Z(ni)}. Suppose that each individual independently selects treatment
with probability α. In this scenario, each individual’s set of potential outcomes can be sum-
marized by weighted averages. Let piα(ω|z) = Prα(zi(j) = ω|zij = z). The average potential
outcome for individual j in group i given zij = z equals
Y¯ij(z;α) =
∑
ω∈Z(ni−1)
piα(ω|z)Yij(zij = z; zi(j) = ω)
=
∑
ω∈Z(ni−1)
α|ω|(1− α)ni−1−|ω|Yij(zij = z; zi(j) = ω)
in which zi(j) ∈ Z(ni − 1) is the treatment vector of all individuals in group i except j, and
|ω| denotes the sum of ω. The group i average potential outcome on treatment z = 0, 1
under treatment strategy α equals Y¯i(z;α) = n
−1
i
∑ni
j=1 Y¯ij(z;α). Finally, let Fz,α be the
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distribution function of Y¯i(z;α), and define
µz,α ≡ E[Y¯i(z;α)] =
∫ 1
0
ydFz,α(y)
Let piα(x) = Prα(zi = x). Assuming that each individual independently selects treatment
with probability α, the average potential outcome for individual j in group i under α is equal
to
Y¯ij(α) =
∑
ω∈Z(ni)
piα(ω)Yij(zi = ω)
=
∑
ω∈Z(ni)
α|ω|(1− α)ni−|ω|Yij(zi = ω)
=
∑
z=0,1
∑
ω′∈Z(ni−1)
αz(1− α)1−zα|ω′|(1− α)ni−1−|ω′|Yij(zij = z; zi(j) = ω′)
= (1− α)Y¯ij(0;α) + αY¯ij(1;α) (4.9)
The group i average potential outcome under treatment strategy α is equal to Y¯i(α) =
n−1i
∑ni
j=1 Y¯ij(α). Finally, let µα ≡ E[Y¯i(α)] = (1− α)µ0,α + αµ1,α.
Extending Hudgens and Halloran (2008) to the superpopulation setting, the inferential
targets are
DE(α) = µ0,α − µ1,α
IE(α, α′) = µ0,α − µ0,α′
TE(α, α′) = µ0,α − µ1,α′
OE(α, α′) = µα − µα′ (4.10)
The observed data reveal for group i = 1, . . . , k the treatment vector Zi = (Zi1, . . . , Zini),
covariates Xi, and outcome vector Yi = (Yi1, . . . , Yini).
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4.4.1 Inverse Probability Weighted Estimation
Tchetgen Tchetgen and VanderWeele (2012) showed that
Yˆ IPWi (z;α) =
1
ni
ni∑
j=1
piα(Zi(j)|Zij)1{Zij = z}Yij
Pr[Zi|Xi] (4.11)
and
Yˆ IPWi (α) =
1
ni
ni∑
j=1
piα(Zi)Yij
Pr[Zi|Xi] (4.12)
are unbiased for Y¯i(z;α) and Y¯i(α), respectively, in a finite population setup assuming (4.3)
when the propensity score Pr[Zi|Xi] is known. The estimators (4.11) and (4.12) are also
unbiased in the superpopulation setting, as in the following propositions:
Proposition 4.1. E[Yˆ IPWi (z;α)] = µz,α
Proposition 4.2. E[Yˆ IPWi (α)] = µα
Proofs of Proposition 4.1 and 4.2 are given in the Appendix. In observational studies,
Pr[Zi = z|Xi] is rarely known and must be estimated, e.g., by a regression model. The
product of individual level model predicted probabilities serves as the estimator P̂r[Zi|Xi].
When the propensity score is known or estimated correctly, Perez-Heydrich et al. (2014, Web
appendix) use M-estimation theory to show that the IPW estimators in (4.4) are consistent
for their target parameters and asymptotically normal. Additionally, they present sandwich
variance estimators to be used in confidence intervals.
4.4.2 Outcome Modeling
As noted previously, under partial interference, individual j in group i has 2ni potential
outcomes. As ni increases, the computational difficulties associated with this problem mount
considerably. In many settings, it may be reasonable to consider functional assumptions about
interference
Yij(zij = z, zi(j) = ω) = Yij(zij = z, zi(j) = ω
′) ∀ ω, ω′ ∈ Z(ni − 1) s.t. f(ω) = f(ω′) (4.13)
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Under (4.13), an individual’s potential outcome on treatment z = 0, 1 is the same when some
function of the other ni − 1 treatment assignments maps to the same value. At one extreme,
when f(x) = x, each individual has 2ni potential outcomes, and at the other extreme when
f(x) = 0, each individual only has two potential outcomes (no interference). One reasonable
function is f(x) = 1{|x| > 0}, where |x| denotes the sum of the elements in x. Under this
threshold function, each individual has four potential outcomes, {yij(zij = z, 1{|zi(j)| > 0} =
c)} for z, c = 0, 1. Another reasonable assumption is stratified interference, or the function
f(x) = |x|. Under this assumption, each individual has 2ni potential outcomes. The purpose
of the functional assumption (4.13) is to simplify the problem, mapping the 2ni group vector
assignments to the real line. Under (4.13), for z = 0, 1
Y¯ij(z;α) =
∑
c∈C
{∑
ω:f(ω)=c piα(zi(j) = ω|zij = z)
}
Yij(zij = z; f(zi(j)) = c)
A statistical model for E[Yij(zij = z; f(zi(j)) = c)] can be used for inference on the causal
effects (4.10), e.g.,
L(Pr[Yij(zij = z; f(zi(j)) = c) = 1]) = β0 + β1z + β2c+ ηXi (4.14)
in which Pr[Yij(zij = z; f(zi(j)) = c) = 1] = E[Yij(zij = z; f(zi(j)) = c)] as Y is binary.
The parameter estimates for model (4.14), the resulting causal effect estimators, and the
corresponding large sample distributions can be derived also using M-estimation theory.
4.4.3 A Bayesian Approach
A Bayesian approach to evaluating causal exposure-outcome relationships in observational
studies with interference is outlined in this section. Although similar to the outcome modeling
approach, the Bayesian approach has the key advantage of accommodating missing covariate
data in a straightforward manner, an important feature given that the DHS contain missing
covariate data. Using model (4.14) for the potential outcomes, let θ = (β0, β1, β2, η). Inference
on the causal effects is carried out by sampling from their posterior distributions using an
analogous Gibbs sampler to the one outlined in Section 2. In this Gibbs sampler, each
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individual will have greater than or equal to two potential outcomes, so that Y mis will be of
length greater than or equal to one for each individual. The causal effects (4.10) are functions
of θ and can be directly computed in step 3 of the Gibbs sampler.
4.4.4 A Simulation Study
To study the proposed methods, the naive, IPW, outcome, and Bayesian point and in-
terval estimators were compared in a simulation study motivated by the DHS that assumed
stratified interference. As will become clear in the simulation below, the true causal effects
were functions of µz,α =
EX,ni
1
ni
ni∑
j=1
ni−1∑
c=0
(
ni − 1
c
)
αc(1− α)ni−1−cL−1
(
β0 + β1z + β2
z + c
ni
+ β3Xij + β4z
z + c
ni
)
(4.15)
and µα = (1− α)µ0,α + αµ1,α. The derivation of (4.15) is given in the appendix.
The simulation proceeded as follows:
1. For group i = 1, . . . , k, ni was randomly sampled from f(ni)
2. For individual j in group i, a Xij was randomly sampled from f(X)
3. For individual j in group i, bed net status Zij was self-selected using the following model
Zij ∼ Bernoulli(L−1(γ0 + γ1Xij)) (4.16)
4. Given Zi = (Zij , Zi(j)) from step 3, an observed malaria outcome for individual j in
group i was generated using the model
Yij(zij = z, zi(j) = ω) ∼ Bernoulli(L−1(β0+β1z+β2(|ω|+z)/ni+β3Xij+β4z(|ω|+z)/ni))
(4.17)
5. To mimic a two-stage randomized experiment, for groups where
∑
j Zij/ni ∈ [αs −
w,αs + w], Si was set to equal s = 0, 1. Groups who did not meet these criteria
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were excluded and the estimators of Hudgens and Halloran (2008) and Wald-type 95%
confidence intervals of Liu and Hudgens (2014) were computed as the naive estimators.
6. IPW estimators and 95% confidence intervals were computed wherein the propensity
scores were treated as known.
7. IPW estimators and 95% confidence intervals were computed wherein the propensity
scores were estimated using the correct model (4.16).
8. Outcome frequentist estimators and 95% confidence intervals were computed using the
correct model (4.17).
9. Bayesian posterior means and 95% credible intervals were computed using the correct
model (4.17) and the priors βm ∼ Normal(0, 4) for m = 0, . . . , 3 with a burn-in of 1100,
a thinning interval of 3, and 1000 samples for the posterior distribution.
10. Steps 1-9 were repeated 1000 times.
The simulations with interference were also motivated by the DHS such that for individual
j in group i, Yij(zi) was the binary potential malaria outcome, Zij was the binary exposure of
bed net use,
∑
j Zij/ni was the proportion of bed net use in group i, and Xij was the binary
confounder of proximity to an urban space. The distributions of ni and X were estimated from
the DHS such that ni ranged from 4-52 with a mean of 29.48 and such that Pr[X = 1] = 0.45.
In computing the naive estimator, w = 0.05. The parameters in models (4.16) and (4.17)
were estimated using the DHS such that γ0 = −1.61, γ1 = 0.47, β0 = −0.47, β1 = −0.40,
β2 = −0.13, β3 = −0.63, β4 = −0.06. Additional simulation inputs are summarized in
Figure 4.1.
Simulation results are given in Figure 4.2 for α = 0, 0.1, . . . , 1. The IPW estimators can be
biased, can have ESE/ASE ratios much larger than 1, can fail to achieve nominal coverage, and
can have much larger widths than outcome models whereas the outcome models are unbiased,
have ESE/ASE ratios near 1, achieve nominal coverage, and have sensible widths. The overall
performance of the IPW estimators was noticeably worse for α values in low probability areas
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of the observed range of group coverage, i.e., α ≤ 0.1 or α ≥ 0.4. For example, IPW estimators
for α = 0.2 had good operating characteristics whereas IPW estimators for α = 0.8 had poor
operating characteristics.
4.5 Analysis of the DHS
The Bayesian method discussed above was applied to the DHS. Based on expert opinion,
the confounders age, sex, urban, time to water source, roof materials, density of agriculture
in 10 km, rain, and air temperature in celsius were included in the outcome model for malaria
in addition to bed net at the individual and group level. The variables malaria, bed net, age,
sex, and urban were fully observed whereas time to water source, roof materials, agricultural
density, rain, and air temperature had varying degrees of missingness less than 2.3%.
In the first Bayesian model, only fully observed variables were entered into the outcome
model
L(Pr[malariaij = 1]) = b0 + b1bednetij + b2propi + b3ageij + b4sexij
+ b5urbanij + b6bednetijpropi
(4.18)
and Normal(0, 4) priors were specified for all model parameters. A burn-in of 1100, a thin-
ning interval of 3, and 1000 samples for the posterior distribution were used. Results are
summarized in Table 4.3 for α ∈ {0.2, 0.5, 0.8}.
In the second Bayesian model, all of the variables were entered into the outcome model
L(Pr[malariaij = 1]) = b0 + b1bednetij + b2propi + b3ageij + b4sexij
+ b5urbanij + b6time2H2Oij + b7roofij
+ b8agric10kmij + b9rainij + b10tempi + b11bednetijpropi
(4.19)
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and the variables with missingness were modeled in lower level hierarchies: time2H2O as a
function of urban, roof as a function of urban, agric10km as a function of urban, rain as a
function of temp and temp with only an intercept. Again Normal(0, 4) priors were specified
for all model parameters and the hierarchical models for the missing variables were normally
distributed with common variance σ2 that had a Uniform(0, 100) prior. A burn-in of 1100, a
thinning interval of 3, and 1000 samples for the posterior distribution were used. Results are
summarized in Table 4.3 for α ∈ {0.2, 0.5, 0.8}.
Model 4.19 may be more plausible than model 4.18 as it handles missing data in a rea-
sonable manner rather than discarding any observations with missing data as in model 4.18.
Complete case analyses such as model 4.18 may lead to bias (Little and Rubin, 1989), so the
inferences from model 4.19 will be discussed. When treating 20% of the population with a
bed net, the direct effect of bed net on malaria is about a 7% reduction. Treating 50% and
80% of the population reduces this direct effect to about a 6% reduction in malaria.
The spillover effect is most pronounced when α0 = 0.2 and α1 = 0.8 such that an individual
not using a bed net in a group with 20% coverage is about 3% more likely to contract malaria
relative to an individual not using a bed net in a group with 80% coverage. This indirect
effect narrowly reaches statistical significance as the lower limit to the credible interval is
greater than zero.
The total effect and overall effects also reach statistical significance at α0 = 0.2 and
α1 = 0.8. An individual not using a bed net in a group with 20% coverage is about 8% more
likely to contract malaria than an individual using a bed net in a group with 80% coverage.
Any individual in a group with 20% coverage is about 6% more likely to contract malaria
than an individual in a group with 80% coverage.
4.6 Discussion
The finding of a spillover effect that is statistically significant is in line with the Messina
et al. (2011) finding that community level bed net use is a significant predictor of malaria
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outcome whereas individual level use is not. The magnitude of the spillover effect was about
1/2 as large as the direct effect of bed net use. A spillover effect beyond the direct effect of
bed net use may be in line with findings of Hii et al. (2001) and Hawley et al. (2003). This
important public health finding lends more support to the argument that sleeping under bed
nets in the DRC should we a widespread practice if malaria prevention is the goal.
One key difference between our methods and the methods in Messina et al. (2011) is
that our approach only used one bed net variable (whether or not an individual slept under
treated net last night) to define individual and community level bed net use whereas Messina
et al. (2011) used four (number of household bed nets, whether or not household has bed
net, whether or not an individual slept under treated net last night, and whether or not an
individual slept under an untreated net last night). In fact in the DHS the variable whether
or not household has bed net is a function of the number of household bed nets.
As individuals self-selected bed nets in the DHS, Bayesian outcome models for malaria
risk were used to adjust for the potential confounding in the DHS. The Bayesian outcome
model may be preferred to the frequentist outcome model as it does not rely upon large
sample theory and can handle missing covariate data in an intuitive manner. The Bayesian
outcome model may be preferred to IPW estimation due to better operating characteristics
in this setting as shown in the simulation study in section 4.4.4. Other papers confirm the
point that IPW estimators have the potential for instability when weights are small enough
(Kang and Schafer, 2007; Freedman and Berk, 2008).
A future direction of this research is to carry out similar Bayesian causal analyses in
the DHS using the other three bed net variables rather than whether or not household has
a bed net to further explore the relationship between bed net use and malaria outcome at
the individual and community level. The reliability and validity of self-report of whether or
not an individual slept under a bed net last night as a proxy of bed net use could also be
investigated.
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4.7 Tables and Figures
Table 4.1: Estimated malaria outcome by bed net status in 300 communities in 2007 DHS
stratified by quartile of community bed net use
No bed net Bed net Total
Quartile Malaria Total Prop Malaria Total Prop Malaria Total Prop
0-4 631 1817 0.35 107 409 0.26 738 2226 0.33
4-14 531 1718 0.31 118 506 0.23 649 2224 0.29
14-32 567 1769 0.32 79 424 0.19 646 2193 0.29
32-100 545 1762 0.31 107 439 0.24 652 2201 0.30
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Table 4.2: Empirical bias and variance for point estimators of τ , and width and coverage for
interval estimators of τ where n is sample size
Point estimator Interval estimator
Method n Bias ESE ASE Coverage Width
Naive 50 0.015 0.15 0.15 0.88 0.57
200 0.017 0.081 0.075 0.91 0.29
1000 0.016 0.035 0.034 0.91 0.13
IPW oracle 50 0.0013 0.18 0.17 0.90 0.68
200 0.0029 0.096 0.090 0.92 0.35
1000 0.0020 0.041 0.041 0.95 0.16
IPW 50 0.0015 0.16 0.14 0.85 0.55
200 0.0044 0.083 0.077 0.92 0.30
1000 0.0018 0.036 0.035 0.94 0.14
Outcome 50 0.0013 0.15 0.15 0.88 0.58
200 0.0033 0.082 0.076 0.92 0.30
1000 0.0022 0.036 0.035 0.94 0.14
Bayes 50 -0.013 0.12 0.13 0.97 0.52
200 0.00052 0.078 0.074 0.93 0.29
1000 0.0017 0.035 0.034 0.94 0.13
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Table 4.3: Results of Bayesian models for DHS data
Model 4.18 Model 4.19
Effect Estimate 95% Credible Interval Estimate 95% Credible Interval
DE(0.2) 0.0670 0.0440 0.090 0.063 0.0380 0.084
DE(0.5) 0.0620 0.0210 0.100 0.060 0.0190 0.097
DE(0.8) 0.057 -0.0180 0.130 0.054 -0.01500 0.120
IE(0.2, 0.5) 0.0082 -0.0068 0.024 0.013 -0.0015 0.028
IE(0.2, 0.8) 0.016 -0.0150 0.044 0.028 0.00065 0.055
TE(0.2, 0.5) 0.0700 0.0300 0.110 0.073 0.0350 0.110
TE(0.2, 0.8) 0.073 0.0038 0.140 0.083 0.01800 0.140
OE(0.2, 0.5) 0.0260 0.0061 0.044 0.031 0.0140 0.047
OE(0.2, 0.8) 0.048 -0.0030 0.098 0.059 0.00730 0.100
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Figure 4.1: Summary of inputs in simulation study in Section 4.4.4
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Figure 4.2: Summary of operating characteristics in simulation study in Section 4.4.4 where
circle=Naive, triangle=IPW, plus=IPW estimated PS, x=outcome, and diamond=Bayes
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APPENDIX A: TECHNICAL DETAILS FOR CHAPTER 2
Proof of Proposition 2.1
Let LD = L0 + L1, UD = U0 + U1, A1 = A1(Z, δ), and A0 = A0(Z, δ). Recall that
nτ =
∑
δj . After observing the data, A
1 ∈ A1, where A1 = {−∑ZjYj , ...,∑Zj(1 − Yj)}.
Therefore:
(LD ≤ nτ ≤ UD) =∑
a1∈A1
(LD ≤ nτ ≤ UD|A1 = a1)(A1 = a1)
≥
∑
a1∈[L1,U1]
(LD ≤ A0 + a1 ≤ UD|A1 = a1)(A1 = a1)
=
∑
a1∈[L1,U1]
(LD − a1 ≤ A0 ≤ UD − a1|A1 = a1)(A1 = a1)
=
∑
a1∈[L1,U1]
(L0 + (L1 − a1) ≤ A0 ≤ U0 + (U1 − a1)|A1 = a1)(A1 = a1)
≥
∑
a1∈[L1,U1]
(L0 ≤ A0 ≤ U0|A1 = a1)(A1 = a1)
= (L0 ≤ A0 ≤ U0, L1 ≤ A1 ≤ U1)
≥ (L0 ≤ A0 ≤ U0) + (L1 ≤ A1 ≤ U1)− 1
= 1− α
where the first inequality follows because [L1, U1] ⊆ A1, the second inequality is true because
for all a1 ∈ [L1, U1], L1 − a1 ≤ 0 and U1 − a1 ≥ 0, and the third inequality follows from the
Bonferroni inequality.
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APPENDIX B: TECHNICAL DETAILS FOR CHAPTER 4
Proof of Proposition 4.1
E[Yˆ IPWi (z;α)] = EX
EY |X
 1ni
ni∑
j=1
EZ|Y,X
(
piα(Zi(j)|Zij)1{Zij = z}Yij
Pr[Zi = zi|Xi]
)

= EXEY |X
 1ni
ni∑
j=1
∑
ω∈Z(ni−1)
(
piα(Zi(j) = ω|Zij = z)Yij(Zij = z, Zi(j) = ω)
Pr[Zi(j) = ω,Zij = z]−1 Pr[Zi(j) = ω,Zij = z|Xi]
)
= EX
EY |X
 1
ni
ni∑
j=1
∑
ω∈Z(ni−1)
piα(Zi(j) = ω|Zij = z)Yij(Zij = z, Zi(j) = ω)

= EX{EY |X(Y¯i(z;α))} = µz,α
Proof of Proposition 4.2
E[Yˆ IPWi (α)] = EXEY |X
 1ni
ni∑
j=1
EZ|Y,X
(
piα(Zi)Yij
Pr[Zi = zi|Xi]
)
= EXEY |X
 1ni
ni∑
j=1
∑
ω∈Z(ni)
(
piα(Zi = ω) Pr[Zi = ω]Yij(Zi = ω)
Pr[Zi = ω|Xi]
)
= EX
EY |X
 1
ni
ni∑
j=1
∑
ω∈Z(ni)
piα(Zi = ω)Yij(Zi = ω)

= EX{EY |X(Y¯i(α))} = µα
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Derivation of causal effect in simulation study in Section 4.4.4
µz,α = E[Y¯i(z;α)]
= EX,ni
{
EY |X,ni [Y¯i(z;α)|X,ni]
}
= EX,ni
1
ni
ni∑
j=1
ni−1∑
c=0
(
ni − 1
c
)
αc(1− α)ni−1−cL−1(β0 + β1z + β2(z + c)/ni + β3Xij)
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